data_1yz2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yz2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.091 -1.603 . . . . 1.31 109.091 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 155.73 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -1.054 . . . . 1.8 110.79 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.27 158.68 2.98 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.641 0.734 . . . . 1.47 111.819 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 36.5 t -174.26 152.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.67 110.923 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.631 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.9 m-20 -107.6 178.03 4.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.575 -0.703 . . . . 1.26 109.496 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.69 -67.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 120.979 -1.076 . . . . 1.84 108.906 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.6 p90 -63.87 -37.59 87.95 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.647 0.736 . . . . 1.85 109.535 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.1 t -96.51 95.51 8.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.856 0.836 . . . . 1.52 109.718 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -86.55 140.47 29.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.156 -0.965 . . . . 1.08 110.447 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -98.25 -14.5 20.26 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.069 . . . . 1.06 110.082 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 64.8 m -89.57 108.18 19.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 0.57 109.882 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -51.84 -42.89 62.94 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 1.1 110.421 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.59 48.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.063 -0.655 . . . . 1.24 110.009 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.64 131.03 3.72 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.828 -1.177 . . . . 0.86 110.276 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.87 124.89 18.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.521 -0.988 . . . . 2.13 109.761 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.91 17.21 11.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.81 112.958 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.4 -59.38 0.07 Allowed 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 118.725 0.693 . . . . 1.61 111.941 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 2.7 m-85 -136.65 13.78 3.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.526 -0.734 . . . . 2.04 110.602 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.36 146.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 121.301 -0.874 . . . . 1.61 109.726 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -95.92 127.35 41.86 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.255 -0.903 . . . . 0.75 111.396 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 1.76 110.321 179.649 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.955 0 N-CA-C 111.023 -0.831 . . . . 0.5 111.023 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.61 -178.79 3.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.291 . . . . 0.73 110.781 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -66.01 151.13 47.5 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.268 -0.895 . . . . 0.95 110.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 21.9 t -170.44 155.32 5.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.155 -0.966 . . . . 0.4 110.925 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -111.39 -171.33 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.62 -0.675 . . . . 0.64 109.859 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.84 -70.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.228 -0.92 . . . . 1.35 108.649 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.4 p90 -60.86 -36.74 79.95 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.839 0.828 . . . . 0.74 109.363 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.1 t -96.81 104.1 16.07 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.306 -0.627 . . . . 0.6 109.306 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.497 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 1.5 mm-40 -98.86 144.59 27.89 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.035 -1.041 . . . . 0.49 111.154 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.61 -4.58 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.086 -1.009 . . . . 0.73 110.72 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 22.0 m -90.07 103.66 16.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.118 -0.989 . . . . 0.36 109.515 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.5 m -50.17 -31.38 13.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.51 -0.744 . . . . 0.62 110.721 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.42 48.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.527 -0.733 . . . . 1.28 110.714 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.65 147.27 16.19 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.8 -1.19 . . . . 0.48 110.699 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.0 48.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -1.024 . . . . 1.63 109.855 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.752 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -118.42 9.95 12.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.153 -0.967 . . . . 0.46 112.156 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -19.19 -63.29 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 118.516 0.598 . . . . 1.24 112.284 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.436 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.36 3.93 4.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.569 -0.707 . . . . 1.82 110.71 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -165.11 144.43 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.311 -0.868 . . . . 1.2 108.991 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.752 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 4.2 t -77.42 88.61 3.79 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.085 -1.01 . . . . 0.45 110.956 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 1.81 109.824 179.412 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.802 0 N-CA-C 110.846 -0.902 . . . . 1.02 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -85.91 -62.73 1.46 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.0 -1.294 . . . . 0.93 110.232 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -173.15 144.61 1.24 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.345 -0.847 . . . . 1.14 110.65 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 35.6 t -172.8 155.15 3.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.376 -0.827 . . . . 0.59 110.256 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.636 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -110.63 -178.59 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.714 . . . . 0.88 110.223 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.42 -64.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.254 -0.904 . . . . 1.42 108.975 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.7 p90 -67.72 -37.82 82.73 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.782 0.801 . . . . 1.0 109.213 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.6 t -94.32 89.16 5.8 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.722 0.772 . . . . 0.81 109.688 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -84.98 139.01 32.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.282 -0.886 . . . . 0.62 109.916 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -126.99 15.29 7.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.966 -1.083 . . . . 1.04 112.187 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -78.23 104.96 9.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.858 -1.151 . . . . 0.9 108.784 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' O ' HG11 ' A' ' 17' ' ' VAL . 95.1 m -46.59 -38.35 9.42 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.459 -0.776 . . . . 1.35 111.271 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 16' ' ' CYS . 5.8 m -141.57 50.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.769 -0.582 . . . . 2.16 110.246 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.72 168.32 38.93 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 119.582 -1.294 . . . . 1.14 111.142 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -80.93 160.67 24.61 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.497 -1.002 . . . . 1.38 110.214 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -138.49 20.07 2.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.025 -1.047 . . . . 0.42 112.756 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.42 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 118.967 0.803 . . . . 1.1 111.774 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.1 10.76 3.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.54 -0.725 . . . . 2.13 110.57 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.506 ' CG1' ' C ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -170.86 147.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 O-C-N 121.3 -0.875 . . . . 1.99 109.214 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 51.6 t -95.2 107.03 19.1 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.831 -1.168 . . . . 0.76 110.76 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.41 HD12 HD11 ' A' ' 23' ' ' ILE . 19.3 mt . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.722 -0.611 . . . . 1.98 109.532 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.737 0 N-CA-C 110.384 -1.087 . . . . 0.47 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.26 169.6 3.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -1.158 . . . . 0.58 111.053 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.08 160.51 26.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.214 -0.929 . . . . 0.81 111.247 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 1.7 t 176.85 156.25 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.449 -0.782 . . . . 0.51 110.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -111.23 -176.56 2.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.854 . . . . 0.7 110.156 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.35 -67.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.271 -0.893 . . . . 1.15 108.654 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.0 p90 -64.17 -35.99 82.6 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.723 0.773 . . . . 0.67 109.371 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.5 t -98.67 95.62 7.38 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.588 0.709 . . . . 0.62 109.204 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -92.98 144.21 25.48 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.121 -0.987 . . . . 0.46 111.208 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -109.17 1.7 20.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.224 -0.922 . . . . 0.61 110.49 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.046 -1.034 . . . . 0.97 108.764 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.0 m -53.55 -28.42 31.52 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.043 -1.035 . . . . 0.58 111.85 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 47.11 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 1.65 110.665 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -161.97 153.0 23.57 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.155 -1.178 . . . . 0.52 110.155 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.65 147.07 41.88 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -1.079 . . . . 1.47 110.176 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -129.77 24.41 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.014 -1.054 . . . . 0.52 112.291 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.37 -58.1 0.05 Allowed 'General case' 0 N--CA 1.513 2.714 0 CA-C-N 118.624 0.647 . . . . 1.07 111.312 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.495 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.77 11.23 2.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 1.39 110.761 178.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -169.25 148.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 121.263 -0.898 . . . . 1.22 109.628 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -88.44 100.23 12.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.115 -0.99 . . . . 0.44 111.321 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.0 mt . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 1.63 109.715 179.04 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.851 0 N-CA-C 110.742 -0.943 . . . . 1.66 110.742 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -68.86 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.078 -1.248 . . . . 2.08 110.266 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m 176.16 149.91 0.13 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.548 -0.72 . . . . 2.02 109.845 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -176.89 156.67 1.37 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.324 -0.86 . . . . 1.19 110.273 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.642 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -110.52 179.96 3.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.442 -0.786 . . . . 1.37 110.152 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.9 -68.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.03 -1.043 . . . . 2.14 108.871 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.1 p90 -61.41 -36.22 79.71 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.763 0.792 . . . . 1.51 109.289 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -99.27 95.39 7.04 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.623 0.725 . . . . 0.96 109.52 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -89.16 137.49 32.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.033 -1.042 . . . . 1.15 109.982 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.37 33.64 5.44 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.996 -1.065 . . . . 1.71 111.37 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.24 100.53 10.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.884 -1.135 . . . . 1.27 109.815 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -36.37 8.34 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.643 -0.661 . . . . 2.25 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.5 53.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.065 -0.654 . . . . 2.57 110.884 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.96 165.47 38.81 Favored Glycine 0 N--CA 1.505 3.249 0 C-N-CA 119.751 -1.214 . . . . 1.48 111.228 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -82.32 168.91 17.08 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.376 -1.073 . . . . 2.31 110.137 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -150.45 27.06 0.75 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.732 -1.23 . . . . 0.9 113.481 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.36 -58.33 0.06 Allowed 'General case' 0 N--CA 1.517 2.914 0 CA-C-N 119.214 0.916 . . . . 2.13 111.948 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -140.28 17.22 2.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.397 -0.814 . . . . 2.91 110.731 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.0 149.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 O-C-N 121.488 -0.758 . . . . 1.89 109.726 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -103.9 134.18 47.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.085 -1.009 . . . . 0.82 110.654 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.497 1.925 0 O-C-N 121.562 -0.711 . . . . 1.72 110.005 179.726 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 N-CA-C 110.768 -0.933 . . . . 0.47 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 7' ' ' SER . 8.4 tt0 -72.1 -62.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.279 . . . . 0.61 109.792 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER 178.39 157.22 0.45 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.654 . . . . 1.36 109.916 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.0 t -179.28 143.61 0.21 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.228 -0.92 . . . . 0.44 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.69 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 5.2 m-20 -105.3 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.149 -0.686 . . . . 0.75 109.149 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.45 -64.67 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 1.17 108.477 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -65.15 -36.61 84.79 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.723 0.773 . . . . 0.54 109.355 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.69 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.9 t -96.46 95.28 7.91 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.882 0.849 . . . . 0.62 110.054 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -90.45 134.14 34.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.184 -0.947 . . . . 0.68 109.345 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -113.64 23.16 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.767 -1.208 . . . . 0.69 112.062 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 73.7 m -87.87 97.85 11.15 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.726 -1.234 . . . . 0.37 109.556 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -45.5 -38.5 6.32 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.478 -0.764 . . . . 0.77 110.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.87 51.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 120.316 -0.553 . . . . 1.26 110.819 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -166.56 174.77 42.01 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 119.91 -1.138 . . . . 0.39 110.735 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -88.22 155.88 19.52 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.353 -1.086 . . . . 1.25 109.956 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -140.56 28.36 2.01 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.889 -1.132 . . . . 0.4 112.513 -178.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -23.6 -60.18 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 O-C-N 121.686 -0.633 . . . . 1.14 111.827 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.409 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.82 16.56 2.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.563 -0.711 . . . . 1.44 110.18 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.78 152.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 O-C-N 121.534 -0.729 . . . . 1.6 109.472 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 8.0 t -105.6 139.51 40.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.753 -1.217 . . . . 0.26 110.983 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 121.635 0.731 . . . . 1.43 109.521 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.92 -1.272 . . . . 0.87 109.92 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.06 169.7 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -1.077 . . . . 1.57 110.685 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -59.14 158.0 9.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.398 -0.814 . . . . 0.8 111.623 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.435 ' CB ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -178.44 138.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.58 109.921 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.658 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -105.73 179.01 4.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.536 -0.728 . . . . 0.84 109.53 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.06 -65.67 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.188 -0.945 . . . . 1.69 108.721 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.55 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.9 p90 -67.46 -38.39 84.38 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.743 0.782 . . . . 1.4 109.253 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -95.05 91.1 6.18 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.771 0.796 . . . . 1.13 109.2 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.28 132.49 33.9 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.058 -1.026 . . . . 1.01 109.976 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -96.19 2.82 53.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.839 -1.163 . . . . 1.35 110.73 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.451 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.8 m -101.83 103.24 13.93 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.238 -0.914 . . . . 0.47 109.849 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 96.4 m -52.24 -33.56 42.06 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.47 -0.769 . . . . 0.81 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 17' ' ' VAL . 7.8 p -137.93 45.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.766 0.793 . . . . 1.25 110.217 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.1 137.94 6.78 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.094 -1.202 . . . . 0.47 110.094 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.95 133.31 51.5 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.54 -0.976 . . . . 2.03 109.601 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.637 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -125.74 11.54 7.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.925 -1.109 . . . . 0.67 112.941 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.25 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 118.701 0.682 . . . . 1.56 112.304 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -135.09 10.2 3.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.405 -0.809 . . . . 2.2 110.832 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.01 156.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 121.183 -0.948 . . . . 1.4 109.655 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -100.35 127.65 46.61 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.006 -1.059 . . . . 0.52 111.394 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.413 HG21 ' O ' ' A' ' 25' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.5 2.044 0 O-C-N 121.628 -0.67 . . . . 1.84 110.088 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.853 0 N-CA-C 110.768 -0.933 . . . . 0.72 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -83.29 -63.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.192 -1.181 . . . . 0.63 110.442 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -173.17 151.21 2.04 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.363 -0.836 . . . . 0.5 110.393 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 51.1 t -167.16 158.16 11.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.237 -0.915 . . . . 0.37 110.552 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.3 OUTLIER -109.04 179.88 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.582 -0.698 . . . . 0.45 109.566 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.13 -69.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.971 -1.08 . . . . 1.23 108.779 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.2 p90 -60.22 -38.23 82.75 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.827 0.822 . . . . 0.45 109.133 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -94.04 102.42 14.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.559 0.695 . . . . 0.38 109.96 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -88.02 131.16 34.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.196 -0.94 . . . . 0.56 109.678 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -118.84 23.56 11.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.786 -1.197 . . . . 0.79 112.037 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -95.33 101.95 13.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.913 -1.117 . . . . 0.68 109.267 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.94 -37.36 8.88 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.549 -0.719 . . . . 1.26 111.533 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.34 52.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 119.614 -0.835 . . . . 1.71 110.364 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -166.31 164.66 37.74 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.736 -1.221 . . . . 0.59 110.972 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.56 157.99 33.12 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.448 -1.031 . . . . 1.74 109.708 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -139.61 19.02 2.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.707 -1.245 . . . . 0.37 113.527 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -22.83 -59.8 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 CA-C-N 119.367 0.985 . . . . 1.18 111.743 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' C ' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -140.61 14.95 2.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.661 -0.649 . . . . 1.23 110.124 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.493 HD11 HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -170.57 140.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.319 -0.863 . . . . 1.26 109.399 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.688 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.1 t -94.32 110.42 22.18 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.716 -1.24 . . . . 0.47 110.547 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.493 HD13 HD11 ' A' ' 23' ' ' ILE . 13.6 mt . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.572 . . . . 1.8 109.472 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.725 0 N-CA-C 111.676 -0.569 . . . . 1.14 111.676 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -74.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.064 1.432 . . . . 1.21 110.736 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -176.12 155.52 1.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.02 -1.05 . . . . 0.77 110.234 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 39.6 t 179.73 153.22 0.47 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.974 . . . . 0.62 111.617 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.648 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -112.53 -178.37 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.727 -0.842 . . . . 0.85 108.727 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 1.3 mp -77.83 -68.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.781 -1.199 . . . . 1.81 108.723 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.8 p90 -62.09 -36.79 82.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.676 0.75 . . . . 1.37 109.686 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.648 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -96.03 96.67 9.03 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.653 0.74 . . . . 0.85 110.141 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -86.31 135.07 33.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.103 -0.998 . . . . 0.91 109.71 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.5 m-80 -101.67 -11.96 18.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.87 -1.144 . . . . 0.77 110.861 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 55.0 m -85.6 103.73 14.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.26 -0.9 . . . . 0.85 109.906 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.2 m -50.16 -36.84 31.86 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.378 -0.826 . . . . 1.32 110.36 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.88 51.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 120.071 -0.652 . . . . 1.99 110.614 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.32 142.56 9.03 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.547 -1.311 . . . . 0.89 110.783 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.12 129.87 43.51 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -1.043 . . . . 1.44 109.402 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.36 14.49 12.05 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.521 -0.872 . . . . 0.63 113.285 -178.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.02 -63.32 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 118.633 0.651 . . . . 1.44 112.497 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.425 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.49 12.85 3.23 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.806 . . . . 2.12 110.794 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.87 156.59 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 1.39 109.251 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -106.97 127.85 53.82 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.01 -1.056 . . . . 0.57 111.476 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 121.556 0.693 . . . . 1.42 109.864 179.35 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.853 -1.299 . . . . 0.58 109.853 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 157.32 12.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -1.131 . . . . 0.61 111.059 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -52.07 156.21 1.65 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.556 0.693 . . . . 1.42 111.95 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 42.7 t -170.19 148.35 3.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.491 -0.756 . . . . 0.48 110.829 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.646 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.8 m-20 -104.33 175.96 5.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.827 . . . . 0.67 109.865 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.12 -71.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.069 -1.02 . . . . 1.55 108.973 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -58.36 -36.92 74.2 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.702 0.763 . . . . 1.02 109.602 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.2 t -97.21 97.21 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.758 0.79 . . . . 0.7 109.765 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.32 145.15 32.26 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.158 -0.964 . . . . 0.72 110.359 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 1.9 m-80 -103.17 -16.41 15.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.965 -1.085 . . . . 0.45 110.552 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 2.3 m -81.13 107.69 14.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.139 -0.976 . . . . 0.42 109.653 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -49.5 -37.83 28.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.249 -0.907 . . . . 0.74 109.991 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.82 52.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 120.184 -0.607 . . . . 1.42 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -159.01 155.43 26.5 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.424 -1.369 . . . . 0.49 110.951 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 t -71.76 148.51 46.25 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.417 -1.049 . . . . 1.17 109.903 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -142.73 24.61 1.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.082 -1.011 . . . . 0.4 112.537 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.39 -58.15 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 118.706 0.685 . . . . 0.72 111.993 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.2 15.1 2.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.47 -0.769 . . . . 1.91 110.691 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.77 147.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 O-C-N 121.374 -0.829 . . . . 1.21 109.276 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.0 t -100.74 138.33 37.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.076 -1.015 . . . . 0.34 112.318 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.645 0.736 . . . . 1.38 109.368 178.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 N-CA-C 110.818 -0.913 . . . . 1.74 110.818 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.78 -63.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.984 -1.304 . . . . 2.0 110.687 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 79.7 p -164.21 165.26 22.18 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.249 -0.907 . . . . 1.49 110.429 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 25.8 t -178.62 145.8 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.146 -0.971 . . . . 0.83 111.826 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.2 m-20 -110.77 174.86 5.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.76 108.599 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -81.22 -70.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.924 -1.11 . . . . 2.05 108.771 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 12' ' ' SER . 32.1 p90 -58.92 -36.0 74.01 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.696 0.76 . . . . 1.56 109.404 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.3 t -97.67 95.93 7.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.577 0.703 . . . . 1.22 110.072 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -74.53 132.98 42.3 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.12 -0.988 . . . . 1.57 109.775 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.4 m-80 -96.14 -37.4 10.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.128 . . . . 0.98 111.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 m -53.75 113.51 1.22 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.17 -0.956 . . . . 1.2 110.025 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.0 m -45.69 -40.67 9.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.371 -0.831 . . . . 1.81 110.741 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -144.27 47.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.31 0.576 . . . . 2.34 109.853 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.75 157.91 27.51 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.566 -1.302 . . . . 1.3 110.806 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -64.21 150.32 46.09 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.956 . . . . 2.02 109.667 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -147.3 25.26 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.156 -1.018 . . . . 1.37 112.859 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.71 -59.86 0.09 Allowed 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 118.973 0.806 . . . . 2.13 111.376 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.43 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -138.66 17.04 2.7 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.626 -0.671 . . . . 2.59 110.346 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -171.55 144.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 O-C-N 121.193 -0.942 . . . . 2.31 109.979 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.597 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.5 t -99.35 112.52 24.68 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.945 -1.097 . . . . 0.73 110.482 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 25' ' ' ILE . 1.6 tt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.919 0.866 . . . . 1.96 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 111.03 -0.828 . . . . 0.75 111.03 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -76.79 -69.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.942 -1.328 . . . . 1.05 110.085 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.4 148.04 4.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.205 -0.935 . . . . 0.92 110.42 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -173.74 148.09 1.44 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.752 . . . . 0.73 110.119 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.663 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -109.85 -176.25 2.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 1.38 109.576 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.82 -65.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 1.57 108.711 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.5 p90 -65.36 -37.14 86.13 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.707 0.765 . . . . 1.3 109.198 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.7 t -94.29 95.54 8.98 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.715 0.769 . . . . 1.08 109.742 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.7 129.41 36.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.298 -0.876 . . . . 0.78 109.847 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.89 19.06 13.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.15 -0.969 . . . . 1.14 111.724 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -93.13 90.47 6.89 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.174 -0.954 . . . . 0.7 109.678 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.7 m -53.45 -32.97 52.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.449 -0.782 . . . . 1.0 111.43 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.1 48.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.288 -0.883 . . . . 2.06 111.307 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . 179.36 171.97 43.02 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.55 -1.31 . . . . 0.67 111.066 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -80.65 165.45 22.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.415 -1.05 . . . . 1.32 109.669 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -142.3 19.17 2.07 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.689 -1.257 . . . . 0.35 113.376 -178.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.13 -60.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.256 0.934 . . . . 1.17 111.63 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.78 13.22 2.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 1.55 110.466 178.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.39 149.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 O-C-N 121.416 -0.803 . . . . 1.36 109.398 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 11.1 t -99.02 112.93 24.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.992 -1.068 . . . . 0.55 110.631 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 23' ' ' ILE . 33.3 mt . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.551 -0.718 . . . . 1.94 109.409 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.877 0 N-CA-C 111.029 -0.828 . . . . 0.98 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.19 -66.64 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.957 -1.319 . . . . 0.97 110.941 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -171.9 146.1 1.98 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.169 -0.957 . . . . 0.52 110.733 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 41.2 t -170.68 154.42 4.45 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.271 -0.893 . . . . 0.5 110.956 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 3.3 m-20 -104.52 -173.51 2.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.705 -0.622 . . . . 0.69 109.898 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -88.53 -66.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.211 -0.93 . . . . 1.44 108.56 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -64.83 -36.85 85.65 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.863 0.84 . . . . 0.99 109.005 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.2 t -94.05 93.65 7.97 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.716 0.77 . . . . 0.78 109.574 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -86.53 133.66 33.72 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.099 -1.001 . . . . 0.61 109.885 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -117.78 12.21 13.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.892 -1.13 . . . . 0.82 111.901 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.71 106.48 8.4 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.936 -1.102 . . . . 0.76 109.323 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.4 m -44.36 -31.5 1.06 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.586 -0.696 . . . . 0.82 111.302 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.427 ' O ' HG11 ' A' ' 17' ' ' VAL . 12.0 p -156.25 49.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.807 0.813 . . . . 1.33 109.957 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.23 168.67 34.14 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.568 -1.301 . . . . 0.64 111.15 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.42 150.57 33.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.574 -0.957 . . . . 2.13 110.043 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -132.91 15.97 4.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.911 -1.118 . . . . 0.6 112.973 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.08 -63.53 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 118.902 0.774 . . . . 1.34 111.974 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.04 11.3 3.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 2.01 110.291 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -169.18 143.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.463 -0.773 . . . . 1.47 108.961 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.67 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 49.3 t -95.71 114.02 25.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.798 -1.189 . . . . 0.63 110.705 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.52 HG21 ' O ' ' A' ' 25' ' ' ILE . 1.4 tp . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.402 0.62 . . . . 1.91 110.137 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 109.643 -1.383 . . . . 0.33 109.643 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.16 151.18 9.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.505 -0.997 . . . . 0.79 111.098 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.28 157.36 0.48 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.464 0.649 . . . . 1.11 111.558 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 41.0 t -170.52 149.31 3.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.251 -0.905 . . . . 0.36 110.914 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.4 m-20 -102.3 -179.23 3.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 0.52 109.586 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.08 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.057 -1.027 . . . . 1.3 108.793 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.6 p90 -57.19 -38.14 73.23 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.739 0.78 . . . . 0.61 109.307 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.0 t -94.37 98.66 11.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.714 0.768 . . . . 0.46 109.647 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.62 140.69 33.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.317 -0.864 . . . . 0.65 110.357 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.0 m-80 -96.65 -19.75 18.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.066 -1.021 . . . . 0.46 110.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.9 m -79.23 111.47 15.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.129 -0.982 . . . . 0.34 109.698 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.31 -35.61 8.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.358 -0.839 . . . . 0.48 109.928 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 17' ' ' VAL . 14.5 p -142.71 52.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.535 0.683 . . . . 1.2 110.2 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.3 151.42 23.47 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.461 -1.352 . . . . 0.29 110.964 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.28 124.85 24.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.476 -1.014 . . . . 1.44 109.589 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -123.76 23.34 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.207 -0.933 . . . . 0.33 112.472 -178.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.51 -56.96 0.08 Allowed 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.628 -0.67 . . . . 1.12 112.084 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -139.23 15.74 2.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.437 -0.79 . . . . 1.74 110.405 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.29 145.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.493 -0.754 . . . . 1.31 109.345 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 29.1 t -99.15 136.46 39.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.27 111.726 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.407 ' O ' HG21 ' A' ' 25' ' ' ILE . 3.8 mt . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.536 0.684 . . . . 1.52 109.553 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.723 0 N-CA-C 110.571 -1.012 . . . . 0.35 110.571 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -170.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.278 . . . . 0.58 110.681 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 146.99 52.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.169 -0.957 . . . . 1.47 111.535 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 19.4 t -171.71 156.46 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.552 -0.717 . . . . 0.42 110.848 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 4.0 m-20 -113.64 -175.33 2.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.68 -0.637 . . . . 0.52 109.915 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.32 -66.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.296 -0.877 . . . . 1.3 108.929 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -69.05 -38.14 78.93 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.745 0.783 . . . . 0.59 109.387 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 5.1 t -94.94 95.85 8.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.807 -0.812 . . . . 0.5 108.807 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.637 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -96.01 150.19 20.74 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.215 -0.928 . . . . 0.55 112.014 -177.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.64 -1.33 15.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.443 -0.785 . . . . 0.61 110.572 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 m -88.17 96.04 10.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.954 -1.091 . . . . 0.39 109.783 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -55.11 -26.15 36.31 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.201 -0.937 . . . . 0.73 110.933 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.45 46.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.203 -0.935 . . . . 1.32 110.802 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -171.55 165.0 37.89 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.411 -1.076 . . . . 0.77 110.411 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -84.26 167.9 16.19 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.335 -1.097 . . . . 1.33 110.382 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.68 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -143.17 24.81 1.78 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.271 -0.893 . . . . 0.72 112.523 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -17.88 -66.75 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 118.582 0.628 . . . . 1.28 111.95 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -131.14 6.47 4.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.539 -0.726 . . . . 2.0 110.815 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.13 152.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.741 -0.837 . . . . 1.31 108.741 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.68 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 30.1 t -86.15 118.04 25.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.45 111.233 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 tp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.316 0.579 . . . . 1.9 110.009 179.562 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.273 -0.64 . . . . 2.32 109.273 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -152.38 154.74 36.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 1.46 110.858 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -77.22 153.43 34.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.405 -0.81 . . . . 4.14 110.543 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . . . -58.68 124.0 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 1.82 109.747 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.82 -27.8 9.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.091 -1.603 . . . . 1.31 109.091 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.89 155.73 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -1.054 . . . . 1.8 110.79 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.27 158.68 2.98 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.641 0.734 . . . . 1.47 111.819 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 36.5 t -174.26 152.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.67 110.923 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.631 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.9 m-20 -107.6 178.03 4.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.575 -0.703 . . . . 1.26 109.496 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.69 -67.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 120.979 -1.076 . . . . 1.84 108.906 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.6 p90 -63.87 -37.59 87.95 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.647 0.736 . . . . 1.85 109.535 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.1 t -96.51 95.51 8.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.856 0.836 . . . . 1.52 109.718 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -86.55 140.47 29.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.156 -0.965 . . . . 1.08 110.447 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -98.25 -14.5 20.26 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.069 . . . . 1.06 110.082 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 26' ' ' GLU . 64.8 m -89.57 108.18 19.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 0.57 109.882 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -51.84 -42.89 62.94 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 1.1 110.421 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.59 48.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.063 -0.655 . . . . 1.24 110.009 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.64 131.03 3.72 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.828 -1.177 . . . . 0.86 110.276 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.87 124.89 18.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.521 -0.988 . . . . 2.13 109.761 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.91 17.21 11.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.81 112.958 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.4 -59.38 0.07 Allowed 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 118.725 0.693 . . . . 1.61 111.941 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 2.7 m-85 -136.65 13.78 3.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.526 -0.734 . . . . 2.04 110.602 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.36 146.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 121.301 -0.874 . . . . 1.61 109.726 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -95.92 127.35 41.86 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.255 -0.903 . . . . 0.75 111.396 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 3.1 mt -123.95 55.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 1.76 110.321 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 1.171 ' HG2' ' N ' ' A' ' 27' ' ' NH2 . 17.9 tt0 -122.3 -126.91 0.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.003 -1.061 . . . . 1.2 110.286 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . 1.171 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.38 1.893 0 O-C-N 119.325 -2.109 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 120.98 0.419 . . . . 0.51 110.128 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -142.35 -160.94 1.16 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.481 -0.762 . . . . 0.92 110.816 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.4 mt-30 -79.19 154.13 29.49 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.347 -0.845 . . . . 1.12 111.777 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.35 142.57 54.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.485 -0.76 . . . . 1.26 111.042 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.43 -13.54 66.24 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 120.486 -0.864 . . . . 0.5 111.023 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 3.3 mt-10 -73.61 -178.79 3.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.291 . . . . 0.73 110.781 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -66.01 151.13 47.5 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.268 -0.895 . . . . 0.95 110.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 21.9 t -170.44 155.32 5.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.155 -0.966 . . . . 0.4 110.925 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -111.39 -171.33 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.62 -0.675 . . . . 0.64 109.859 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.84 -70.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.228 -0.92 . . . . 1.35 108.649 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.4 p90 -60.86 -36.74 79.95 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.839 0.828 . . . . 0.74 109.363 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.1 t -96.81 104.1 16.07 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.306 -0.627 . . . . 0.6 109.306 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 1.5 mm-40 -98.86 144.59 27.89 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.035 -1.041 . . . . 0.49 111.154 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 2.9 t-20 -108.61 -4.58 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.086 -1.009 . . . . 0.73 110.72 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 22.0 m -90.07 103.66 16.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.118 -0.989 . . . . 0.36 109.515 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.5 m -50.17 -31.38 13.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.51 -0.744 . . . . 0.62 110.721 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.42 48.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.527 -0.733 . . . . 1.28 110.714 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.65 147.27 16.19 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.8 -1.19 . . . . 0.48 110.699 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.0 48.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -1.024 . . . . 1.63 109.855 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.752 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -118.42 9.95 12.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.153 -0.967 . . . . 0.46 112.156 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -19.19 -63.29 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 118.516 0.598 . . . . 1.24 112.284 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.436 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.36 3.93 4.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.569 -0.707 . . . . 1.82 110.71 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -165.11 144.43 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.311 -0.868 . . . . 1.2 108.991 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.752 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 4.2 t -77.42 88.61 3.79 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.085 -1.01 . . . . 0.45 110.956 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.35 114.99 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 1.81 109.824 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -114.89 169.17 9.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.874 . . . . 1.5 110.755 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.927 0 O-C-N 119.348 -2.095 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 120.755 0.312 . . . . 1.14 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -130.44 174.22 10.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.421 -0.8 . . . . 0.96 110.151 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.68 151.34 30.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.198 -0.939 . . . . 1.87 110.693 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -58.78 126.98 29.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 1.63 110.012 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.27 7.53 72.49 Favored Glycine 0 N--CA 1.498 2.802 0 C-N-CA 120.291 -0.957 . . . . 1.02 110.846 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -85.91 -62.73 1.46 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.0 -1.294 . . . . 0.93 110.232 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -173.15 144.61 1.24 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.345 -0.847 . . . . 1.14 110.65 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 35.6 t -172.8 155.15 3.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.376 -0.827 . . . . 0.59 110.256 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.636 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -110.63 -178.59 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.714 . . . . 0.88 110.223 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.42 -64.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.254 -0.904 . . . . 1.42 108.975 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.7 p90 -67.72 -37.82 82.73 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.782 0.801 . . . . 1.0 109.213 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.6 t -94.32 89.16 5.8 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.722 0.772 . . . . 0.81 109.688 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -84.98 139.01 32.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.282 -0.886 . . . . 0.62 109.916 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -126.99 15.29 7.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.966 -1.083 . . . . 1.04 112.187 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -78.23 104.96 9.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.858 -1.151 . . . . 0.9 108.784 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' O ' HG11 ' A' ' 17' ' ' VAL . 95.1 m -46.59 -38.35 9.42 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.459 -0.776 . . . . 1.35 111.271 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG22 ' HG3' ' A' ' 26' ' ' GLU . 5.8 m -141.57 50.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.769 -0.582 . . . . 2.16 110.246 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.72 168.32 38.93 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 119.582 -1.294 . . . . 1.14 111.142 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -80.93 160.67 24.61 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.497 -1.002 . . . . 1.38 110.214 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -138.49 20.07 2.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.025 -1.047 . . . . 0.42 112.756 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.42 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 118.967 0.803 . . . . 1.1 111.774 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.1 10.76 3.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.54 -0.725 . . . . 2.13 110.57 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.506 ' CG1' ' C ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -170.86 147.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 O-C-N 121.3 -0.875 . . . . 1.99 109.214 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 51.6 t -95.2 107.03 19.1 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.831 -1.168 . . . . 0.76 110.76 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.41 HD12 HD11 ' A' ' 23' ' ' ILE . 19.3 mt -118.99 100.92 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.722 -0.611 . . . . 1.98 109.532 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HG3' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -79.24 147.42 32.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.42 -0.8 . . . . 2.3 110.639 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.914 0 O-C-N 119.275 -2.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 109.986 -0.375 . . . . 1.03 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.829 ' HE2' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -174.95 -173.8 0.72 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.416 -0.802 . . . . 1.01 111.128 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.535 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -85.88 169.65 13.1 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.115 -0.99 . . . . 1.04 110.729 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.98 135.01 51.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.806 -1.184 . . . . 1.22 109.499 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.63 52.03 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.384 -1.087 . . . . 0.47 110.384 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.26 169.6 3.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -1.158 . . . . 0.58 111.053 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.08 160.51 26.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.214 -0.929 . . . . 0.81 111.247 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 1.7 t 176.85 156.25 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.449 -0.782 . . . . 0.51 110.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -111.23 -176.56 2.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.854 . . . . 0.7 110.156 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.35 -67.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.271 -0.893 . . . . 1.15 108.654 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.0 p90 -64.17 -35.99 82.6 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.723 0.773 . . . . 0.67 109.371 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.5 t -98.67 95.62 7.38 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.588 0.709 . . . . 0.62 109.204 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -92.98 144.21 25.48 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.121 -0.987 . . . . 0.46 111.208 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -109.17 1.7 20.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.224 -0.922 . . . . 0.61 110.49 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.046 -1.034 . . . . 0.97 108.764 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.0 m -53.55 -28.42 31.52 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.043 -1.035 . . . . 0.58 111.85 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 47.11 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 1.65 110.665 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -161.97 153.0 23.57 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.155 -1.178 . . . . 0.52 110.155 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.65 147.07 41.88 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -1.079 . . . . 1.47 110.176 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -129.77 24.41 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.014 -1.054 . . . . 0.52 112.291 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.37 -58.1 0.05 Allowed 'General case' 0 N--CA 1.513 2.714 0 CA-C-N 118.624 0.647 . . . . 1.07 111.312 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.77 11.23 2.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 1.39 110.761 178.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -169.25 148.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 121.263 -0.898 . . . . 1.22 109.628 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.829 ' SG ' ' HE2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -88.44 100.23 12.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.115 -0.99 . . . . 0.44 111.321 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.0 mt -117.5 118.94 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 1.63 109.715 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.33 136.82 45.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.365 -0.834 . . . . 1.31 110.316 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 1.944 0 O-C-N 119.438 -2.039 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 75.6 m . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.009 0.433 . . . . 2.53 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 13.0 mttt -125.12 161.77 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 2.18 110.422 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -69.95 167.57 17.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.401 -0.812 . . . . 2.21 111.411 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -65.73 116.76 7.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.292 -0.88 . . . . 1.21 110.181 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.24 -3.72 69.79 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 120.18 -1.01 . . . . 1.66 110.742 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -66.98 -68.86 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.078 -1.248 . . . . 2.08 110.266 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m 176.16 149.91 0.13 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.548 -0.72 . . . . 2.02 109.845 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -176.89 156.67 1.37 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.324 -0.86 . . . . 1.19 110.273 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.642 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -110.52 179.96 3.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.442 -0.786 . . . . 1.37 110.152 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.9 -68.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.03 -1.043 . . . . 2.14 108.871 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.1 p90 -61.41 -36.22 79.71 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.763 0.792 . . . . 1.51 109.289 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -99.27 95.39 7.04 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.623 0.725 . . . . 0.96 109.52 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -89.16 137.49 32.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.033 -1.042 . . . . 1.15 109.982 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -116.37 33.64 5.44 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.996 -1.065 . . . . 1.71 111.37 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.24 100.53 10.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.884 -1.135 . . . . 1.27 109.815 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -36.37 8.34 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.643 -0.661 . . . . 2.25 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.5 53.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.065 -0.654 . . . . 2.57 110.884 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.96 165.47 38.81 Favored Glycine 0 N--CA 1.505 3.249 0 C-N-CA 119.751 -1.214 . . . . 1.48 111.228 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -82.32 168.91 17.08 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.376 -1.073 . . . . 2.31 110.137 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -150.45 27.06 0.75 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.732 -1.23 . . . . 0.9 113.481 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.36 -58.33 0.06 Allowed 'General case' 0 N--CA 1.517 2.914 0 CA-C-N 119.214 0.916 . . . . 2.13 111.948 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -140.28 17.22 2.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.397 -0.814 . . . . 2.91 110.731 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.0 149.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 O-C-N 121.488 -0.758 . . . . 1.89 109.726 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -103.9 134.18 47.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.085 -1.009 . . . . 0.82 110.654 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.04 61.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.562 -0.711 . . . . 1.72 110.005 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.08 139.92 48.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.086 -1.009 . . . . 1.43 110.451 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.934 0 O-C-N 119.343 -2.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 1.2 m . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.144 0.497 . . . . 0.8 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -145.16 136.79 25.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.76 110.247 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 171.76 3.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 2.61 110.521 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -63.18 110.21 1.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.175 -0.953 . . . . 1.08 110.553 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.7 61.95 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.768 -0.933 . . . . 0.47 110.768 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' OE2' ' HG3' ' A' ' 2' ' ' LYS . 8.4 tt0 -72.1 -62.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.279 . . . . 0.61 109.792 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER 178.39 157.22 0.45 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.654 . . . . 1.36 109.916 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.0 t -179.28 143.61 0.21 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.228 -0.92 . . . . 0.44 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.69 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 5.2 m-20 -105.3 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.149 -0.686 . . . . 0.75 109.149 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.45 -64.67 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 1.17 108.477 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -65.15 -36.61 84.79 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.723 0.773 . . . . 0.54 109.355 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.69 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.9 t -96.46 95.28 7.91 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.882 0.849 . . . . 0.62 110.054 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -90.45 134.14 34.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.184 -0.947 . . . . 0.68 109.345 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.63 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 2.2 m-80 -113.64 23.16 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.767 -1.208 . . . . 0.69 112.062 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 73.7 m -87.87 97.85 11.15 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.726 -1.234 . . . . 0.37 109.556 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -45.5 -38.5 6.32 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.478 -0.764 . . . . 0.77 110.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.87 51.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 120.316 -0.553 . . . . 1.26 110.819 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -166.56 174.77 42.01 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 119.91 -1.138 . . . . 0.39 110.735 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -88.22 155.88 19.52 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.353 -1.086 . . . . 1.25 109.956 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -140.56 28.36 2.01 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.889 -1.132 . . . . 0.4 112.513 -178.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -23.6 -60.18 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 O-C-N 121.686 -0.633 . . . . 1.14 111.827 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.409 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.82 16.56 2.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.563 -0.711 . . . . 1.44 110.18 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.78 152.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 O-C-N 121.534 -0.729 . . . . 1.6 109.472 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 8.0 t -105.6 139.51 40.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.753 -1.217 . . . . 0.26 110.983 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.08 64.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.635 0.731 . . . . 1.43 109.521 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.93 109.76 7.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 1.45 110.845 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.864 0 O-C-N 119.293 -2.13 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.109 0.48 . . . . 0.96 109.85 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -130.11 135.63 48.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.551 -0.718 . . . . 1.16 109.757 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -53.43 155.33 2.95 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.512 -0.742 . . . . 2.4 111.558 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.48 129.82 29.9 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.321 -0.862 . . . . 1.41 110.88 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.23 -26.14 19.68 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.92 -1.272 . . . . 0.87 109.92 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 2.5 mm-40 -65.06 169.7 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -1.077 . . . . 1.57 110.685 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.508 ' OG ' ' NZ ' ' A' ' 2' ' ' LYS . 1.6 p -59.14 158.0 9.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.398 -0.814 . . . . 0.8 111.623 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.435 ' CB ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -178.44 138.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.58 109.921 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.658 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -105.73 179.01 4.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.536 -0.728 . . . . 0.84 109.53 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.06 -65.67 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.188 -0.945 . . . . 1.69 108.721 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.55 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.9 p90 -67.46 -38.39 84.38 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.743 0.782 . . . . 1.4 109.253 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -95.05 91.1 6.18 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.771 0.796 . . . . 1.13 109.2 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.28 132.49 33.9 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.058 -1.026 . . . . 1.01 109.976 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' OD1' ' HE3' ' A' ' 2' ' ' LYS . 2.2 m-80 -96.19 2.82 53.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.839 -1.163 . . . . 1.35 110.73 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 38.8 m -101.83 103.24 13.93 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.238 -0.914 . . . . 0.47 109.849 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 96.4 m -52.24 -33.56 42.06 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.47 -0.769 . . . . 0.81 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 17' ' ' VAL . 7.8 p -137.93 45.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.766 0.793 . . . . 1.25 110.217 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.1 137.94 6.78 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.094 -1.202 . . . . 0.47 110.094 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.95 133.31 51.5 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.54 -0.976 . . . . 2.03 109.601 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.637 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -125.74 11.54 7.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.925 -1.109 . . . . 0.67 112.941 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.25 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 118.701 0.682 . . . . 1.56 112.304 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -135.09 10.2 3.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.405 -0.809 . . . . 2.2 110.832 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.01 156.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 121.183 -0.948 . . . . 1.4 109.655 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -100.35 127.65 46.61 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.006 -1.059 . . . . 0.52 111.394 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.413 HG21 ' O ' ' A' ' 25' ' ' ILE . 2.6 mp -124.5 57.04 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.628 -0.67 . . . . 1.84 110.088 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 2.7 tt0 -87.35 111.31 20.95 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.985 -1.072 . . . . 1.51 110.722 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.929 0 O-C-N 119.282 -2.136 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 3.4 mtpp -136.2 -173.31 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.444 -0.785 . . . . 1.13 110.583 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 4.3 mt-30 -80.28 150.5 29.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.242 -0.911 . . . . 0.96 111.37 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -62.33 126.5 27.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.323 -0.861 . . . . 1.35 110.352 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.46 3.13 82.17 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.768 -0.933 . . . . 0.72 110.768 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 3' ' ' GLN . 2.3 tt0 -83.29 -63.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.192 -1.181 . . . . 0.63 110.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.435 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 1.6 m -173.17 151.21 2.04 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.363 -0.836 . . . . 0.5 110.393 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 51.1 t -167.16 158.16 11.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.237 -0.915 . . . . 0.37 110.552 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.3 OUTLIER -109.04 179.88 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.582 -0.698 . . . . 0.45 109.566 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.13 -69.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.971 -1.08 . . . . 1.23 108.779 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.2 p90 -60.22 -38.23 82.75 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.827 0.822 . . . . 0.45 109.133 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -94.04 102.42 14.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.559 0.695 . . . . 0.38 109.96 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -88.02 131.16 34.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.196 -0.94 . . . . 0.56 109.678 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 4.3 m-80 -118.84 23.56 11.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.786 -1.197 . . . . 0.79 112.037 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -95.33 101.95 13.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.913 -1.117 . . . . 0.68 109.267 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.94 -37.36 8.88 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.549 -0.719 . . . . 1.26 111.533 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.495 HG21 ' HG3' ' A' ' 26' ' ' GLU . 16.4 m -141.34 52.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 119.614 -0.835 . . . . 1.71 110.364 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -166.31 164.66 37.74 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.736 -1.221 . . . . 0.59 110.972 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.56 157.99 33.12 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.448 -1.031 . . . . 1.74 109.708 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -139.61 19.02 2.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.707 -1.245 . . . . 0.37 113.527 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -22.83 -59.8 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 CA-C-N 119.367 0.985 . . . . 1.18 111.743 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' C ' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -140.61 14.95 2.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.661 -0.649 . . . . 1.23 110.124 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.493 HD11 HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -170.57 140.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.319 -0.863 . . . . 1.26 109.399 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.688 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.1 t -94.32 110.42 22.18 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.716 -1.24 . . . . 0.47 110.547 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.493 HD13 HD11 ' A' ' 23' ' ' ILE . 13.6 mt -122.3 135.52 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.572 . . . . 1.8 109.472 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -103.35 160.34 14.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 3.5 110.475 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.926 0 O-C-N 119.423 -2.048 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 1.246 ' H3 ' ' O ' ' A' ' 1' ' ' CYS . 2.3 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.912 -0.403 . . . . 2.03 109.912 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.866 ' HG3' ' H3 ' ' A' ' 1' ' ' CYS . 13.9 mttt -156.27 124.68 5.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.754 -0.591 . . . . 1.03 109.875 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 -57.96 155.88 10.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.443 -0.786 . . . . 1.57 110.806 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -54.88 123.0 12.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -0.827 . . . . 1.57 110.95 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.67 61.65 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 120.376 -0.916 . . . . 1.14 111.676 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -67.16 -74.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.064 1.432 . . . . 1.21 110.736 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -176.12 155.52 1.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.02 -1.05 . . . . 0.77 110.234 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 39.6 t 179.73 153.22 0.47 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.974 . . . . 0.62 111.617 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.648 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -112.53 -178.37 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.727 -0.842 . . . . 0.85 108.727 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 1.3 mp -77.83 -68.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.781 -1.199 . . . . 1.81 108.723 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.8 p90 -62.09 -36.79 82.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.676 0.75 . . . . 1.37 109.686 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.648 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -96.03 96.67 9.03 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.653 0.74 . . . . 0.85 110.141 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -86.31 135.07 33.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.103 -0.998 . . . . 0.91 109.71 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.5 m-80 -101.67 -11.96 18.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.87 -1.144 . . . . 0.77 110.861 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 55.0 m -85.6 103.73 14.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.26 -0.9 . . . . 0.85 109.906 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.2 m -50.16 -36.84 31.86 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.378 -0.826 . . . . 1.32 110.36 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.88 51.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 120.071 -0.652 . . . . 1.99 110.614 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.32 142.56 9.03 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.547 -1.311 . . . . 0.89 110.783 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.12 129.87 43.51 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -1.043 . . . . 1.44 109.402 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.36 14.49 12.05 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.521 -0.872 . . . . 0.63 113.285 -178.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.02 -63.32 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 118.633 0.651 . . . . 1.44 112.497 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.425 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.49 12.85 3.23 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.806 . . . . 2.12 110.794 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.87 156.59 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 1.39 109.251 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -106.97 127.85 53.82 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.01 -1.056 . . . . 0.57 111.476 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.6 mt -123.2 54.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.556 0.693 . . . . 1.42 109.864 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 1.191 ' CG ' ' HN1' ' A' ' 27' ' ' NH2 . 17.8 tt0 -108.88 -146.08 0.4 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 1.22 110.631 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . 1.191 ' HN1' ' CG ' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.38 1.904 0 O-C-N 119.194 -2.191 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.44 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 35.0 m . . . . . 0 N--CA 1.501 2.093 0 N-CA-C 109.724 -0.473 . . . . 1.71 109.724 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -154.49 121.49 5.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.702 . . . . 0.67 110.481 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.61 148.2 16.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.547 -0.72 . . . . 1.8 110.91 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 25' ' ' ILE . . . -49.94 128.85 19.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.407 -0.808 . . . . 0.59 110.598 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.19 -32.74 6.77 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.853 -1.299 . . . . 0.58 109.853 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -59.87 157.32 12.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -1.131 . . . . 0.61 111.059 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -52.07 156.21 1.65 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.556 0.693 . . . . 1.42 111.95 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 42.7 t -170.19 148.35 3.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.491 -0.756 . . . . 0.48 110.829 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.646 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.8 m-20 -104.33 175.96 5.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.827 . . . . 0.67 109.865 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.12 -71.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.069 -1.02 . . . . 1.55 108.973 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -58.36 -36.92 74.2 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.702 0.763 . . . . 1.02 109.602 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.2 t -97.21 97.21 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.758 0.79 . . . . 0.7 109.765 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.32 145.15 32.26 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.158 -0.964 . . . . 0.72 110.359 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 1.9 m-80 -103.17 -16.41 15.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.965 -1.085 . . . . 0.45 110.552 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . 2.3 m -81.13 107.69 14.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.139 -0.976 . . . . 0.42 109.653 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -49.5 -37.83 28.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.249 -0.907 . . . . 0.74 109.991 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.82 52.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 120.184 -0.607 . . . . 1.42 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -159.01 155.43 26.5 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.424 -1.369 . . . . 0.49 110.951 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 t -71.76 148.51 46.25 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.417 -1.049 . . . . 1.17 109.903 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -142.73 24.61 1.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.082 -1.011 . . . . 0.4 112.537 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.39 -58.15 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 118.706 0.685 . . . . 0.72 111.993 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.2 15.1 2.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.47 -0.769 . . . . 1.91 110.691 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.77 147.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 O-C-N 121.374 -0.829 . . . . 1.21 109.276 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.0 t -100.74 138.33 37.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.076 -1.015 . . . . 0.34 112.318 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.516 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.4 mp -128.75 54.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.645 0.736 . . . . 1.38 109.368 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 19.8 tt0 -99.15 175.81 5.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.235 -0.916 . . . . 0.88 110.786 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . 0.475 ' N ' ' CG ' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.381 1.943 0 O-C-N 119.169 -2.207 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 120.941 0.401 . . . . 2.06 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.508 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -151.31 175.91 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.717 -0.614 . . . . 1.69 110.159 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -78.68 144.51 35.27 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 2.03 111.197 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.56 126.99 29.5 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.316 -0.865 . . . . 1.32 110.078 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.92 -2.82 67.26 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.818 -0.913 . . . . 1.74 110.818 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.78 -63.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.984 -1.304 . . . . 2.0 110.687 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 79.7 p -164.21 165.26 22.18 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.249 -0.907 . . . . 1.49 110.429 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 25.8 t -178.62 145.8 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.146 -0.971 . . . . 0.83 111.826 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.2 m-20 -110.77 174.86 5.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.76 108.599 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -81.22 -70.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.924 -1.11 . . . . 2.05 108.771 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 12' ' ' SER . 32.1 p90 -58.92 -36.0 74.01 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.696 0.76 . . . . 1.56 109.404 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.3 t -97.67 95.93 7.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.577 0.703 . . . . 1.22 110.072 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -74.53 132.98 42.3 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.12 -0.988 . . . . 1.57 109.775 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . 2.4 m-80 -96.14 -37.4 10.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.128 . . . . 0.98 111.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 m -53.75 113.51 1.22 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.17 -0.956 . . . . 1.2 110.025 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.0 m -45.69 -40.67 9.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.371 -0.831 . . . . 1.81 110.741 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -144.27 47.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.31 0.576 . . . . 2.34 109.853 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.75 157.91 27.51 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.566 -1.302 . . . . 1.3 110.806 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -64.21 150.32 46.09 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.956 . . . . 2.02 109.667 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -147.3 25.26 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.156 -1.018 . . . . 1.37 112.859 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.71 -59.86 0.09 Allowed 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 118.973 0.806 . . . . 2.13 111.376 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -138.66 17.04 2.7 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.626 -0.671 . . . . 2.59 110.346 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -171.55 144.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 O-C-N 121.193 -0.942 . . . . 2.31 109.979 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.597 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.5 t -99.35 112.52 24.68 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.945 -1.097 . . . . 0.73 110.482 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 25' ' ' ILE . 1.6 tt -114.01 58.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.919 0.866 . . . . 1.96 110.346 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.79 134.75 57.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.131 -0.981 . . . . 1.0 110.73 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.911 0 O-C-N 119.342 -2.099 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 120.926 0.393 . . . . 1.1 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -123.49 153.02 41.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.505 -0.747 . . . . 1.22 110.091 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.72 31.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.186 -0.946 . . . . 1.34 110.226 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.73 123.1 15.25 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 1.22 109.665 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.92 2.77 90.5 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.297 -0.954 . . . . 0.75 111.03 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.59 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 4.6 tt0 -76.79 -69.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.942 -1.328 . . . . 1.05 110.085 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.4 148.04 4.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.205 -0.935 . . . . 0.92 110.42 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -173.74 148.09 1.44 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.752 . . . . 0.73 110.119 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.663 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -109.85 -176.25 2.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 1.38 109.576 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.82 -65.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 1.57 108.711 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.5 p90 -65.36 -37.14 86.13 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.707 0.765 . . . . 1.3 109.198 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.663 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.7 t -94.29 95.54 8.98 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.715 0.769 . . . . 1.08 109.742 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.7 129.41 36.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.298 -0.876 . . . . 0.78 109.847 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -118.89 19.06 13.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.15 -0.969 . . . . 1.14 111.724 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.672 ' SG ' ' HG3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -93.13 90.47 6.89 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.174 -0.954 . . . . 0.7 109.678 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.7 m -53.45 -32.97 52.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.449 -0.782 . . . . 1.0 111.43 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.1 48.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.288 -0.883 . . . . 2.06 111.307 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . 179.36 171.97 43.02 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.55 -1.31 . . . . 0.67 111.066 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -80.65 165.45 22.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.415 -1.05 . . . . 1.32 109.669 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -142.3 19.17 2.07 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.689 -1.257 . . . . 0.35 113.376 -178.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.13 -60.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.256 0.934 . . . . 1.17 111.63 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.78 13.22 2.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 1.55 110.466 178.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.39 149.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 O-C-N 121.416 -0.803 . . . . 1.36 109.398 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 11.1 t -99.02 112.93 24.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.992 -1.068 . . . . 0.55 110.631 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 23' ' ' ILE . 33.3 mt -125.42 88.58 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.551 -0.718 . . . . 1.94 109.409 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.672 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 71.7 mt-10 -80.55 154.22 27.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 2.1 110.832 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.92 0 O-C-N 119.227 -2.17 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.868 -0.419 . . . . 1.2 109.868 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -133.03 175.6 9.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.455 -0.778 . . . . 2.56 110.541 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 2.1 tt0 -80.98 150.24 29.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 1.95 110.581 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' N ' ' HG2' ' A' ' 3' ' ' GLN . . . -60.71 131.44 50.71 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 1.77 110.133 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.8 70.98 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.491 -0.862 . . . . 0.98 111.029 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 3' ' ' GLN . 3.4 tt0 -83.19 -66.64 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.957 -1.319 . . . . 0.97 110.941 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -171.9 146.1 1.98 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.169 -0.957 . . . . 0.52 110.733 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 41.2 t -170.68 154.42 4.45 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.271 -0.893 . . . . 0.5 110.956 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 3.3 m-20 -104.52 -173.51 2.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.705 -0.622 . . . . 0.69 109.898 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -88.53 -66.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.211 -0.93 . . . . 1.44 108.56 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -64.83 -36.85 85.65 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.863 0.84 . . . . 0.99 109.005 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.2 t -94.05 93.65 7.97 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.716 0.77 . . . . 0.78 109.574 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -86.53 133.66 33.72 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.099 -1.001 . . . . 0.61 109.885 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.679 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 1.9 m-80 -117.78 12.21 13.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.892 -1.13 . . . . 0.82 111.901 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.71 106.48 8.4 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.936 -1.102 . . . . 0.76 109.323 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.4 m -44.36 -31.5 1.06 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.586 -0.696 . . . . 0.82 111.302 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.427 ' O ' HG11 ' A' ' 17' ' ' VAL . 12.0 p -156.25 49.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.807 0.813 . . . . 1.33 109.957 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.23 168.67 34.14 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.568 -1.301 . . . . 0.64 111.15 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.42 150.57 33.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.574 -0.957 . . . . 2.13 110.043 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -132.91 15.97 4.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.911 -1.118 . . . . 0.6 112.973 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.08 -63.53 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 118.902 0.774 . . . . 1.34 111.974 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.04 11.3 3.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 2.01 110.291 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -169.18 143.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.463 -0.773 . . . . 1.47 108.961 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.67 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 49.3 t -95.71 114.02 25.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.798 -1.189 . . . . 0.63 110.705 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.52 HG21 ' O ' ' A' ' 25' ' ' ILE . 1.4 tp -129.08 124.46 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.402 0.62 . . . . 1.91 110.137 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 153.06 30.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.65 110.342 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.891 0 O-C-N 119.361 -2.087 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 109.65 -0.5 . . . . 0.66 109.65 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.36 125.52 5.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.657 -0.652 . . . . 0.67 110.082 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 10.0 mp0 -51.11 149.28 3.83 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.552 0.691 . . . . 1.66 111.446 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 25' ' ' ILE . . . -50.23 132.28 24.01 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.502 -0.749 . . . . 1.04 110.708 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.15 -35.22 5.19 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.643 -1.383 . . . . 0.33 109.643 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -55.16 151.18 9.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.505 -0.997 . . . . 0.79 111.098 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.28 157.36 0.48 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.464 0.649 . . . . 1.11 111.558 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 41.0 t -170.52 149.31 3.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.251 -0.905 . . . . 0.36 110.914 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.4 m-20 -102.3 -179.23 3.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 0.52 109.586 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.08 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.057 -1.027 . . . . 1.3 108.793 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.6 p90 -57.19 -38.14 73.23 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.739 0.78 . . . . 0.61 109.307 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.0 t -94.37 98.66 11.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.714 0.768 . . . . 0.46 109.647 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.62 140.69 33.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.317 -0.864 . . . . 0.65 110.357 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.0 m-80 -96.65 -19.75 18.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.066 -1.021 . . . . 0.46 110.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.9 m -79.23 111.47 15.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.129 -0.982 . . . . 0.34 109.698 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.31 -35.61 8.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.358 -0.839 . . . . 0.48 109.928 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 17' ' ' VAL . 14.5 p -142.71 52.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.535 0.683 . . . . 1.2 110.2 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.3 151.42 23.47 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.461 -1.352 . . . . 0.29 110.964 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.28 124.85 24.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.476 -1.014 . . . . 1.44 109.589 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -123.76 23.34 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.207 -0.933 . . . . 0.33 112.472 -178.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.51 -56.96 0.08 Allowed 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.628 -0.67 . . . . 1.12 112.084 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -139.23 15.74 2.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.437 -0.79 . . . . 1.74 110.405 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.29 145.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.493 -0.754 . . . . 1.31 109.345 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 29.1 t -99.15 136.46 39.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.27 111.726 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.542 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 3.8 mt -126.78 53.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.536 0.684 . . . . 1.52 109.553 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 2' ' ' LYS . 3.2 tt0 -84.11 127.27 33.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.979 -1.076 . . . . 0.72 110.481 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.873 0 O-C-N 119.419 -2.051 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.1 t . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 110.001 -0.37 . . . . 0.59 110.001 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' HG2' ' CD ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -149.87 -174.29 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.555 -0.716 . . . . 1.05 110.549 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 6.4 tp-100 -79.67 152.69 29.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.767 . . . . 1.44 110.559 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -57.41 133.69 55.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.367 -0.833 . . . . 0.74 110.121 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.65 -14.22 64.41 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.571 -1.012 . . . . 0.35 110.571 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -77.06 -170.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.278 . . . . 0.58 110.681 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 146.99 52.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.169 -0.957 . . . . 1.47 111.535 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 19.4 t -171.71 156.46 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.552 -0.717 . . . . 0.42 110.848 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 4.0 m-20 -113.64 -175.33 2.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.68 -0.637 . . . . 0.52 109.915 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.32 -66.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.296 -0.877 . . . . 1.3 108.929 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -69.05 -38.14 78.93 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.745 0.783 . . . . 0.59 109.387 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 5.1 t -94.94 95.85 8.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.807 -0.812 . . . . 0.5 108.807 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.637 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -96.01 150.19 20.74 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.215 -0.928 . . . . 0.55 112.014 -177.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.64 -1.33 15.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.443 -0.785 . . . . 0.61 110.572 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 m -88.17 96.04 10.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.954 -1.091 . . . . 0.39 109.783 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -55.11 -26.15 36.31 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.201 -0.937 . . . . 0.73 110.933 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.45 46.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.203 -0.935 . . . . 1.32 110.802 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.503 ' HA3' ' HG3' ' A' ' 26' ' ' GLU . . . -171.55 165.0 37.89 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.411 -1.076 . . . . 0.77 110.411 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -84.26 167.9 16.19 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.335 -1.097 . . . . 1.33 110.382 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.68 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -143.17 24.81 1.78 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.271 -0.893 . . . . 0.72 112.523 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -17.88 -66.75 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 118.582 0.628 . . . . 1.28 111.95 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -131.14 6.47 4.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.539 -0.726 . . . . 2.0 110.815 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.13 152.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.741 -0.837 . . . . 1.31 108.741 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.68 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 30.1 t -86.15 118.04 25.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.45 111.233 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 tp -140.66 124.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.316 0.579 . . . . 1.9 110.009 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 2.3 mt-10 -122.14 -155.0 0.62 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.226 -0.921 . . . . 1.24 110.797 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.912 0 O-C-N 119.219 -2.176 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.091 -1.603 . . . . 1.1299999999999999 109.091 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 155.73 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -1.054 . . . . 1.8 110.79 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.27 158.68 2.98 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.641 0.734 . . . . 1.23 111.819 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 36.5 t -174.26 152.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.56000000000000005 110.923 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.9 m-20 -107.6 178.03 4.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.575 -0.703 . . . . 1.26 109.496 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.1 mp -77.69 -67.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 120.979 -1.076 . . . . 1.3799999999999999 108.906 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.6 p90 -63.87 -37.59 87.95 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.647 0.736 . . . . 1.75 109.535 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.635 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.1 t -96.51 95.51 8.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.856 0.836 . . . . 1.3400000000000001 109.718 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -86.55 140.47 29.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.156 -0.965 . . . . 0.94999999999999996 110.447 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -98.25 -14.5 20.26 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.069 . . . . 1.0600000000000001 110.082 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 64.8 m -89.57 108.18 19.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 0.56999999999999995 109.882 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -51.84 -42.89 62.94 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 1.1000000000000001 110.421 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.59 48.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.063 -0.655 . . . . 0.59999999999999998 110.009 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.64 131.03 3.72 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.828 -1.177 . . . . 0.70999999999999996 110.276 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.87 124.89 18.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.521 -0.988 . . . . 1.6899999999999999 109.761 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.91 17.21 11.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.68999999999999995 112.958 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.4 -59.38 0.07 Allowed 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 118.725 0.693 . . . . 1.1699999999999999 111.941 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 2.7 m-85 -136.65 13.78 3.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.526 -0.734 . . . . 1.76 110.602 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.36 146.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 121.301 -0.874 . . . . 1.0900000000000001 109.726 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -95.92 127.35 41.86 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.255 -0.903 . . . . 0.75 111.396 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 25' ' ' ILE . 3.1 mt . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 1.1699999999999999 110.321 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . . . . . . 0 N--CA 1.5 2.955 0 N-CA-C 111.023 -0.831 . . . . 0.44 111.023 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.61 -178.79 3.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.291 . . . . 0.47999999999999998 110.781 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -66.01 151.13 47.5 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.268 -0.895 . . . . 0.80000000000000004 110.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 21.9 t -170.44 155.32 5.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.155 -0.966 . . . . 0.38 110.925 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -111.39 -171.33 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.62 -0.675 . . . . 0.64000000000000001 109.859 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.5 mp -83.84 -70.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.228 -0.92 . . . . 0.68999999999999995 108.649 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.4 p90 -60.86 -36.74 79.95 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.839 0.828 . . . . 0.68000000000000005 109.363 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.1 t -96.81 104.1 16.07 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.306 -0.627 . . . . 0.55000000000000004 109.306 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.536 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 1.5 mm-40 -98.86 144.59 27.89 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.035 -1.041 . . . . 0.40999999999999998 111.154 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.61 -4.58 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.086 -1.009 . . . . 0.56000000000000005 110.72 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 22.0 m -90.07 103.66 16.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.118 -0.989 . . . . 0.33000000000000002 109.515 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.5 m -50.17 -31.38 13.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.51 -0.744 . . . . 0.48999999999999999 110.721 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.42 48.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.527 -0.733 . . . . 0.71999999999999997 110.714 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.65 147.27 16.19 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.8 -1.19 . . . . 0.42999999999999999 110.699 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.0 48.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -1.024 . . . . 1.05 109.855 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -118.42 9.95 12.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.153 -0.967 . . . . 0.42999999999999999 112.156 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -19.19 -63.29 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 118.516 0.598 . . . . 0.66000000000000003 112.284 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.436 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.36 3.93 4.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.569 -0.707 . . . . 1.4099999999999999 110.71 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.996 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -165.11 144.43 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.311 -0.868 . . . . 0.56000000000000005 108.991 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.703 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 4.2 t -77.42 88.61 3.79 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.085 -1.01 . . . . 0.45000000000000001 110.956 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.996 HD11 HD12 ' A' ' 23' ' ' ILE . 8.4 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 1.3700000000000001 109.824 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.802 0 N-CA-C 110.846 -0.902 . . . . 0.91000000000000003 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -85.91 -62.73 1.46 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.0 -1.294 . . . . 0.93000000000000005 110.232 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -173.15 144.61 1.24 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.345 -0.847 . . . . 1.1000000000000001 110.65 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 35.6 t -172.8 155.15 3.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.376 -0.827 . . . . 0.53000000000000003 110.256 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -110.63 -178.59 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.714 . . . . 0.88 110.223 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.5 mp -79.42 -64.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.254 -0.904 . . . . 0.89000000000000001 108.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.7 p90 -67.72 -37.82 82.73 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.782 0.801 . . . . 0.93000000000000005 109.213 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.6 t -94.32 89.16 5.8 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.722 0.772 . . . . 0.72999999999999998 109.688 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -84.98 139.01 32.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.282 -0.886 . . . . 0.58999999999999997 109.916 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -126.99 15.29 7.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.966 -1.083 . . . . 0.88 112.187 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -78.23 104.96 9.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.858 -1.151 . . . . 0.90000000000000002 108.784 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m -46.59 -38.35 9.42 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.459 -0.776 . . . . 1.3500000000000001 111.271 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -141.57 50.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.769 -0.582 . . . . 1.6599999999999999 110.246 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.72 168.32 38.93 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 119.582 -1.294 . . . . 1.0800000000000001 111.142 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -80.93 160.67 24.61 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.497 -1.002 . . . . 0.83999999999999997 110.214 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -138.49 20.07 2.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.025 -1.047 . . . . 0.34999999999999998 112.756 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.42 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 118.967 0.803 . . . . 0.56999999999999995 111.774 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.1 10.76 3.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.54 -0.725 . . . . 1.77 110.57 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -170.86 147.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 O-C-N 121.3 -0.875 . . . . 1.49 109.214 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 51.6 t -95.2 107.03 19.1 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.831 -1.168 . . . . 0.76000000000000001 110.76 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.569 HD11 HD12 ' A' ' 23' ' ' ILE . 19.3 mt . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.722 -0.611 . . . . 1.55 109.532 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.737 0 N-CA-C 110.384 -1.087 . . . . 0.39000000000000001 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.26 169.6 3.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -1.158 . . . . 0.57999999999999996 111.053 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.08 160.51 26.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.214 -0.929 . . . . 0.41999999999999998 111.247 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.555 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 1.7 t 176.85 156.25 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.449 -0.782 . . . . 0.34999999999999998 110.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -111.23 -176.56 2.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.854 . . . . 0.69999999999999996 110.156 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.5 mp -78.35 -67.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.271 -0.893 . . . . 0.54000000000000004 108.654 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.0 p90 -64.17 -35.99 82.6 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.723 0.773 . . . . 0.57999999999999996 109.371 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.5 t -98.67 95.62 7.38 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.588 0.709 . . . . 0.56999999999999995 109.204 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.555 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -92.98 144.21 25.48 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.121 -0.987 . . . . 0.42999999999999999 111.208 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -109.17 1.7 20.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.224 -0.922 . . . . 0.52000000000000002 110.49 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.046 -1.034 . . . . 0.75 108.764 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.0 m -53.55 -28.42 31.52 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.043 -1.035 . . . . 0.57999999999999996 111.85 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 47.11 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 1.0 110.665 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -161.97 153.0 23.57 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.155 -1.178 . . . . 0.48999999999999999 110.155 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.65 147.07 41.88 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -1.079 . . . . 0.83999999999999997 110.176 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -129.77 24.41 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.014 -1.054 . . . . 0.46999999999999997 112.291 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.37 -58.1 0.05 Allowed 'General case' 0 N--CA 1.513 2.714 0 CA-C-N 118.624 0.647 . . . . 0.52000000000000002 111.312 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.495 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.77 11.23 2.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 1.03 110.761 178.238 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -169.25 148.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 121.263 -0.898 . . . . 0.51000000000000001 109.628 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -88.44 100.23 12.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.115 -0.99 . . . . 0.44 111.321 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.728 HD11 HD12 ' A' ' 23' ' ' ILE . 25.0 mt . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 1.1200000000000001 109.715 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.851 0 N-CA-C 110.742 -0.943 . . . . 1.6599999999999999 110.742 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -68.86 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.078 -1.248 . . . . 2.0800000000000001 110.266 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m 176.16 149.91 0.13 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.548 -0.72 . . . . 1.9099999999999999 109.845 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -176.89 156.67 1.37 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.324 -0.86 . . . . 1.0600000000000001 110.273 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -110.52 179.96 3.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.442 -0.786 . . . . 1.3700000000000001 110.152 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.537 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.7 mp -79.9 -68.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.03 -1.043 . . . . 1.6299999999999999 108.871 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.1 p90 -61.41 -36.22 79.71 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.763 0.792 . . . . 1.3200000000000001 109.289 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -99.27 95.39 7.04 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.623 0.725 . . . . 0.83999999999999997 109.52 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -89.16 137.49 32.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.033 -1.042 . . . . 0.96999999999999997 109.982 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.37 33.64 5.44 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.996 -1.065 . . . . 1.46 111.37 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.24 100.53 10.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.884 -1.135 . . . . 1.27 109.815 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -36.37 8.34 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.643 -0.661 . . . . 2.25 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.5 53.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.065 -0.654 . . . . 2.2200000000000002 110.884 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.96 165.47 38.81 Favored Glycine 0 N--CA 1.505 3.249 0 C-N-CA 119.751 -1.214 . . . . 1.3999999999999999 111.228 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -82.32 168.91 17.08 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.376 -1.073 . . . . 1.9299999999999999 110.137 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -150.45 27.06 0.75 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.732 -1.23 . . . . 0.90000000000000002 113.481 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.36 -58.33 0.06 Allowed 'General case' 0 N--CA 1.517 2.914 0 CA-C-N 119.214 0.916 . . . . 1.6200000000000001 111.948 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -140.28 17.22 2.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.397 -0.814 . . . . 2.6000000000000001 110.731 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.0 149.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 O-C-N 121.488 -0.758 . . . . 1.55 109.726 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -103.9 134.18 47.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.085 -1.009 . . . . 0.81999999999999995 110.654 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 25' ' ' ILE . 3.3 mt . . . . . 0 N--CA 1.497 1.925 0 O-C-N 121.562 -0.711 . . . . 1.1699999999999999 110.005 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 N-CA-C 110.768 -0.933 . . . . 0.46999999999999997 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 7' ' ' SER . 8.4 tt0 -72.1 -62.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.279 . . . . 0.58999999999999997 109.792 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.9 OUTLIER 178.39 157.22 0.45 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.654 . . . . 0.97999999999999998 109.916 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.0 t -179.28 143.61 0.21 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.228 -0.92 . . . . 0.44 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.701 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 5.2 m-20 -105.3 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.149 -0.686 . . . . 0.75 109.149 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.2 mp -79.45 -64.67 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 0.54000000000000004 108.477 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -65.15 -36.61 84.79 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.723 0.773 . . . . 0.45000000000000001 109.355 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.701 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.9 t -96.46 95.28 7.91 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.882 0.849 . . . . 0.56999999999999995 110.054 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -90.45 134.14 34.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.184 -0.947 . . . . 0.54000000000000004 109.345 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -113.64 23.16 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.767 -1.208 . . . . 0.58999999999999997 112.062 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 73.7 m -87.87 97.85 11.15 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.726 -1.234 . . . . 0.37 109.556 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -45.5 -38.5 6.32 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.478 -0.764 . . . . 0.77000000000000002 110.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.87 51.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 120.316 -0.553 . . . . 0.63 110.819 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -166.56 174.77 42.01 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 119.91 -1.138 . . . . 0.35999999999999999 110.735 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -88.22 155.88 19.52 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.353 -1.086 . . . . 0.59999999999999998 109.956 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -140.56 28.36 2.01 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.889 -1.132 . . . . 0.28000000000000003 112.513 -178.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -23.6 -60.18 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 O-C-N 121.686 -0.633 . . . . 0.42999999999999999 111.827 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.82 16.56 2.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.563 -0.711 . . . . 1.1699999999999999 110.18 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.78 152.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 O-C-N 121.534 -0.729 . . . . 0.85999999999999999 109.472 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 8.0 t -105.6 139.51 40.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.753 -1.217 . . . . 0.26000000000000001 110.983 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 121.635 0.731 . . . . 0.80000000000000004 109.521 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.92 -1.272 . . . . 0.73999999999999999 109.92 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.06 169.7 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -1.077 . . . . 1.5700000000000001 110.685 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -59.14 158.0 9.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.398 -0.814 . . . . 0.64000000000000001 111.623 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -178.44 138.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.57999999999999996 109.921 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -105.73 179.01 4.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.536 -0.728 . . . . 0.81000000000000005 109.53 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.6 mp -74.06 -65.67 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.188 -0.945 . . . . 1.21 108.721 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.55 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.9 p90 -67.46 -38.39 84.38 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.743 0.782 . . . . 1.3200000000000001 109.253 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.671 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -95.05 91.1 6.18 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.771 0.796 . . . . 1.04 109.2 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -87.28 132.49 33.9 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.058 -1.026 . . . . 0.88 109.976 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -96.19 2.82 53.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.839 -1.163 . . . . 1.1200000000000001 110.73 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.451 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.8 m -101.83 103.24 13.93 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.238 -0.914 . . . . 0.46000000000000002 109.849 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 96.4 m -52.24 -33.56 42.06 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.47 -0.769 . . . . 0.81000000000000005 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 17' ' ' VAL . 7.8 p -137.93 45.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.766 0.793 . . . . 0.56999999999999995 110.217 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.1 137.94 6.78 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.094 -1.202 . . . . 0.46999999999999997 110.094 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.95 133.31 51.5 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.54 -0.976 . . . . 1.3300000000000001 109.601 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -125.74 11.54 7.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.925 -1.109 . . . . 0.64000000000000001 112.941 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.25 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 118.701 0.682 . . . . 1.04 112.304 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -135.09 10.2 3.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.405 -0.809 . . . . 1.77 110.832 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.01 156.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 121.183 -0.948 . . . . 0.88 109.655 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -100.35 127.65 46.61 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.006 -1.059 . . . . 0.52000000000000002 111.394 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 25' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.5 2.044 0 O-C-N 121.628 -0.67 . . . . 1.1599999999999999 110.088 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.853 0 N-CA-C 110.768 -0.933 . . . . 0.67000000000000004 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -83.29 -63.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.192 -1.181 . . . . 0.60999999999999999 110.442 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -173.17 151.21 2.04 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.363 -0.836 . . . . 0.40000000000000002 110.393 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 51.1 t -167.16 158.16 11.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.237 -0.915 . . . . 0.34999999999999998 110.552 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.623 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.3 OUTLIER -109.04 179.88 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.582 -0.698 . . . . 0.45000000000000001 109.566 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 21' ' ' ALA . 1.3 mp -85.13 -69.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.971 -1.08 . . . . 0.51000000000000001 108.779 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.2 p90 -60.22 -38.23 82.75 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.827 0.822 . . . . 0.39000000000000001 109.133 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.623 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -94.04 102.42 14.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.559 0.695 . . . . 0.34000000000000002 109.96 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -88.02 131.16 34.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.196 -0.94 . . . . 0.44 109.678 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -118.84 23.56 11.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.786 -1.197 . . . . 0.69999999999999996 112.037 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -95.33 101.95 13.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.913 -1.117 . . . . 0.60999999999999999 109.267 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.94 -37.36 8.88 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.549 -0.719 . . . . 1.26 111.533 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.34 52.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 119.614 -0.835 . . . . 1.0800000000000001 110.364 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -166.31 164.66 37.74 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.736 -1.221 . . . . 0.55000000000000004 110.972 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.56 157.99 33.12 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.448 -1.031 . . . . 1.1100000000000001 109.708 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -139.61 19.02 2.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.707 -1.245 . . . . 0.34999999999999998 113.527 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -22.83 -59.8 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 CA-C-N 119.367 0.985 . . . . 0.44 111.743 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' C ' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -140.61 14.95 2.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.661 -0.649 . . . . 1.0 110.124 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.57 140.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.319 -0.863 . . . . 0.66000000000000003 109.399 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.1 t -94.32 110.42 22.18 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.716 -1.24 . . . . 0.46999999999999997 110.547 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.457 HD11 HD12 ' A' ' 23' ' ' ILE . 13.6 mt . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.572 . . . . 1.29 109.472 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.725 0 N-CA-C 111.676 -0.569 . . . . 1.1399999999999999 111.676 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -74.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.064 1.432 . . . . 1.0900000000000001 110.736 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -176.12 155.52 1.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.02 -1.05 . . . . 0.68999999999999995 110.234 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 39.6 t 179.73 153.22 0.47 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.974 . . . . 0.62 111.617 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.65 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -112.53 -178.37 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.727 -0.842 . . . . 0.77000000000000002 108.727 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.83 -68.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.781 -1.199 . . . . 1.3100000000000001 108.723 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.8 p90 -62.09 -36.79 82.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.676 0.75 . . . . 1.25 109.686 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -96.03 96.67 9.03 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.653 0.74 . . . . 0.84999999999999998 110.141 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -86.31 135.07 33.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.103 -0.998 . . . . 0.82999999999999996 109.71 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -101.67 -11.96 18.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.87 -1.144 . . . . 0.77000000000000002 110.861 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 55.0 m -85.6 103.73 14.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.26 -0.9 . . . . 0.84999999999999998 109.906 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.2 m -50.16 -36.84 31.86 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.378 -0.826 . . . . 1.27 110.36 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.88 51.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 120.071 -0.652 . . . . 1.55 110.614 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.32 142.56 9.03 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.547 -1.311 . . . . 0.89000000000000001 110.783 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.12 129.87 43.51 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -1.043 . . . . 0.81999999999999995 109.402 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.36 14.49 12.05 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.521 -0.872 . . . . 0.54000000000000004 113.285 -178.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.02 -63.32 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 118.633 0.651 . . . . 0.89000000000000001 112.497 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.425 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.49 12.85 3.23 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.806 . . . . 1.74 110.794 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.87 156.59 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 0.81000000000000005 109.251 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -106.97 127.85 53.82 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.01 -1.056 . . . . 0.56999999999999995 111.476 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 121.556 0.693 . . . . 0.78000000000000003 109.864 179.35 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.853 -1.299 . . . . 0.54000000000000004 109.853 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 157.32 12.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -1.131 . . . . 0.48999999999999999 111.059 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -52.07 156.21 1.65 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.556 0.693 . . . . 0.90000000000000002 111.95 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -170.19 148.35 3.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.491 -0.756 . . . . 0.47999999999999998 110.829 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.659 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.8 m-20 -104.33 175.96 5.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.827 . . . . 0.63 109.865 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.4 mp -78.12 -71.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.069 -1.02 . . . . 0.90000000000000002 108.973 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -58.36 -36.92 74.2 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.702 0.763 . . . . 0.93000000000000005 109.602 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.659 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.2 t -97.21 97.21 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.758 0.79 . . . . 0.65000000000000002 109.765 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.32 145.15 32.26 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.158 -0.964 . . . . 0.62 110.359 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -103.17 -16.41 15.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.965 -1.085 . . . . 0.44 110.552 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 2.3 m -81.13 107.69 14.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.139 -0.976 . . . . 0.41999999999999998 109.653 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -49.5 -37.83 28.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.249 -0.907 . . . . 0.73999999999999999 109.991 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.82 52.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 120.184 -0.607 . . . . 0.91000000000000003 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -159.01 155.43 26.5 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.424 -1.369 . . . . 0.46000000000000002 110.951 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 t -71.76 148.51 46.25 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.417 -1.049 . . . . 0.5 109.903 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -142.73 24.61 1.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.082 -1.011 . . . . 0.38 112.537 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.39 -58.15 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 118.706 0.685 . . . . 0.60999999999999999 111.993 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.2 15.1 2.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.47 -0.769 . . . . 1.5800000000000001 110.691 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.77 147.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 O-C-N 121.374 -0.829 . . . . 0.62 109.276 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.0 t -100.74 138.33 37.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.076 -1.015 . . . . 0.34000000000000002 112.318 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.645 0.736 . . . . 0.69999999999999996 109.368 178.922 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 N-CA-C 110.818 -0.913 . . . . 1.74 110.818 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.78 -63.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.984 -1.304 . . . . 1.8500000000000001 110.687 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 79.7 p -164.21 165.26 22.18 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.249 -0.907 . . . . 1.26 110.429 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 25.8 t -178.62 145.8 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.146 -0.971 . . . . 0.68000000000000005 111.826 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.666 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.2 m-20 -110.77 174.86 5.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.76000000000000001 108.599 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.2 mp -81.22 -70.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.924 -1.11 . . . . 1.55 108.771 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 12' ' ' SER . 32.1 p90 -58.92 -36.0 74.01 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.696 0.76 . . . . 1.48 109.404 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.666 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.3 t -97.67 95.93 7.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.577 0.703 . . . . 1.01 110.072 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -74.53 132.98 42.3 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.12 -0.988 . . . . 1.3600000000000001 109.775 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.4 m-80 -96.14 -37.4 10.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.128 . . . . 0.97999999999999998 111.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 m -53.75 113.51 1.22 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.17 -0.956 . . . . 1.2 110.025 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.0 m -45.69 -40.67 9.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.371 -0.831 . . . . 1.8100000000000001 110.741 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -144.27 47.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.31 0.576 . . . . 2.0099999999999998 109.853 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.75 157.91 27.51 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.566 -1.302 . . . . 1.22 110.806 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -64.21 150.32 46.09 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.956 . . . . 1.79 109.667 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -147.3 25.26 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.156 -1.018 . . . . 1.1899999999999999 112.859 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.71 -59.86 0.09 Allowed 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 118.973 0.806 . . . . 1.8500000000000001 111.376 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.43 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -138.66 17.04 2.7 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.626 -0.671 . . . . 2.25 110.346 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -171.55 144.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 O-C-N 121.193 -0.942 . . . . 1.8700000000000001 109.979 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.5 t -99.35 112.52 24.68 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.945 -1.097 . . . . 0.69999999999999996 110.482 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 25' ' ' ILE . 1.6 tt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.919 0.866 . . . . 1.49 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 111.03 -0.828 . . . . 0.75 111.03 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -76.79 -69.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.942 -1.328 . . . . 1.05 110.085 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.4 148.04 4.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.205 -0.935 . . . . 0.84999999999999998 110.42 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -173.74 148.09 1.44 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.752 . . . . 0.72999999999999998 110.119 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -109.85 -176.25 2.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 1.3799999999999999 109.576 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.4 mp -79.82 -65.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 1.1100000000000001 108.711 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.5 p90 -65.36 -37.14 86.13 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.707 0.765 . . . . 1.1499999999999999 109.198 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.667 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.7 t -94.29 95.54 8.98 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.715 0.769 . . . . 1.01 109.742 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.7 129.41 36.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.298 -0.876 . . . . 0.58999999999999997 109.847 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.89 19.06 13.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.15 -0.969 . . . . 0.93999999999999995 111.724 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -93.13 90.47 6.89 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.174 -0.954 . . . . 0.57999999999999996 109.678 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.7 m -53.45 -32.97 52.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.449 -0.782 . . . . 0.94999999999999996 111.43 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.1 48.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.288 -0.883 . . . . 1.46 111.307 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . 179.36 171.97 43.02 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.55 -1.31 . . . . 0.57999999999999996 111.066 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -80.65 165.45 22.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.415 -1.05 . . . . 0.67000000000000004 109.669 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -142.3 19.17 2.07 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.689 -1.257 . . . . 0.32000000000000001 113.376 -178.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.13 -60.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.256 0.934 . . . . 0.55000000000000004 111.63 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.78 13.22 2.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 1.29 110.466 178.713 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.39 149.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 O-C-N 121.416 -0.803 . . . . 0.75 109.398 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 11.1 t -99.02 112.93 24.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.992 -1.068 . . . . 0.55000000000000004 110.631 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 23' ' ' ILE . 33.3 mt . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.551 -0.718 . . . . 1.3700000000000001 109.409 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.877 0 N-CA-C 111.029 -0.828 . . . . 0.82999999999999996 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.19 -66.64 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.957 -1.319 . . . . 0.96999999999999997 110.941 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -171.9 146.1 1.98 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.169 -0.957 . . . . 0.5 110.733 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.636 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 41.2 t -170.68 154.42 4.45 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.271 -0.893 . . . . 0.5 110.956 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.611 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 3.3 m-20 -104.52 -173.51 2.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.705 -0.622 . . . . 0.68999999999999995 109.898 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.1 mp -88.53 -66.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.211 -0.93 . . . . 0.89000000000000001 108.56 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -64.83 -36.85 85.65 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.863 0.84 . . . . 0.93999999999999995 109.005 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.611 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.2 t -94.05 93.65 7.97 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.716 0.77 . . . . 0.68000000000000005 109.574 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -86.53 133.66 33.72 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.099 -1.001 . . . . 0.54000000000000004 109.885 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -117.78 12.21 13.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.892 -1.13 . . . . 0.73999999999999999 111.901 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.71 106.48 8.4 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.936 -1.102 . . . . 0.72999999999999998 109.323 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.4 m -44.36 -31.5 1.06 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.586 -0.696 . . . . 0.81999999999999995 111.302 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.0 p -156.25 49.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.807 0.813 . . . . 0.60999999999999999 109.957 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.23 168.67 34.14 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.568 -1.301 . . . . 0.59999999999999998 111.15 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.42 150.57 33.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.574 -0.957 . . . . 1.5900000000000001 110.043 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -132.91 15.97 4.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.911 -1.118 . . . . 0.56000000000000005 112.973 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.08 -63.53 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 118.902 0.774 . . . . 0.79000000000000004 111.974 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.04 11.3 3.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 1.6899999999999999 110.291 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -169.18 143.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.463 -0.773 . . . . 1.03 108.961 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 49.3 t -95.71 114.02 25.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.798 -1.189 . . . . 0.63 110.705 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 25' ' ' ILE . 1.4 tp . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.402 0.62 . . . . 1.26 110.137 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 109.643 -1.383 . . . . 0.33000000000000002 109.643 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.16 151.18 9.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.505 -0.997 . . . . 0.79000000000000004 111.098 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.28 157.36 0.48 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.464 0.649 . . . . 0.67000000000000004 111.558 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.0 t -170.52 149.31 3.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.251 -0.905 . . . . 0.33000000000000002 110.914 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.646 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.4 m-20 -102.3 -179.23 3.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 0.52000000000000002 109.586 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.08 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.057 -1.027 . . . . 0.59999999999999998 108.793 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.6 p90 -57.19 -38.14 73.23 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.739 0.78 . . . . 0.54000000000000004 109.307 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.0 t -94.37 98.66 11.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.714 0.768 . . . . 0.42999999999999999 109.647 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.62 140.69 33.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.317 -0.864 . . . . 0.51000000000000001 110.357 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -96.65 -19.75 18.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.066 -1.021 . . . . 0.38 110.473 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.9 m -79.23 111.47 15.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.129 -0.982 . . . . 0.26000000000000001 109.698 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.31 -35.61 8.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.358 -0.839 . . . . 0.41999999999999998 109.928 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 17' ' ' VAL . 14.5 p -142.71 52.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.535 0.683 . . . . 0.52000000000000002 110.2 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.3 151.42 23.47 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.461 -1.352 . . . . 0.28000000000000003 110.964 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.28 124.85 24.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.476 -1.014 . . . . 0.77000000000000002 109.589 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -123.76 23.34 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.207 -0.933 . . . . 0.27000000000000002 112.472 -178.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.51 -56.96 0.08 Allowed 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.628 -0.67 . . . . 0.40000000000000002 112.084 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -139.23 15.74 2.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.437 -0.79 . . . . 1.3999999999999999 110.405 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.29 145.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.493 -0.754 . . . . 0.66000000000000003 109.345 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 29.1 t -99.15 136.46 39.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.27000000000000002 111.726 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 25' ' ' ILE . 3.8 mt . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.536 0.684 . . . . 0.88 109.553 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.723 0 N-CA-C 110.571 -1.012 . . . . 0.34000000000000002 110.571 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -170.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.278 . . . . 0.57999999999999996 110.681 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 146.99 52.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.169 -0.957 . . . . 1.0800000000000001 111.535 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.669 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 19.4 t -171.71 156.46 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.552 -0.717 . . . . 0.38 110.848 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 4.0 m-20 -113.64 -175.33 2.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.68 -0.637 . . . . 0.52000000000000002 109.915 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.0 mp -78.32 -66.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.296 -0.877 . . . . 0.56000000000000005 108.929 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -69.05 -38.14 78.93 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.745 0.783 . . . . 0.52000000000000002 109.387 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 5.1 t -94.94 95.85 8.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.807 -0.812 . . . . 0.5 108.807 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.669 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -96.01 150.19 20.74 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.215 -0.928 . . . . 0.45000000000000001 112.014 -177.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.64 -1.33 15.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.443 -0.785 . . . . 0.48999999999999999 110.572 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 m -88.17 96.04 10.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.954 -1.091 . . . . 0.33000000000000002 109.783 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -55.11 -26.15 36.31 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.201 -0.937 . . . . 0.68999999999999995 110.933 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.45 46.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.203 -0.935 . . . . 0.75 110.802 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -171.55 165.0 37.89 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.411 -1.076 . . . . 0.77000000000000002 110.411 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -84.26 167.9 16.19 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.335 -1.097 . . . . 0.79000000000000004 110.382 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -143.17 24.81 1.78 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.271 -0.893 . . . . 0.68999999999999995 112.523 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -17.88 -66.75 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 118.582 0.628 . . . . 0.72999999999999998 111.95 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -131.14 6.47 4.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.539 -0.726 . . . . 1.6599999999999999 110.815 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.13 152.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.741 -0.837 . . . . 0.70999999999999996 108.741 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.623 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 30.1 t -86.15 118.04 25.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.45000000000000001 111.233 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 25' ' ' ILE . 1.3 tp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.316 0.579 . . . . 1.3799999999999999 110.009 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 2.0 m . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.273 -0.64 . . . . 1.6699999999999999 109.273 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -152.38 154.74 36.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 1.3100000000000001 110.858 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -77.22 153.43 34.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.405 -0.81 . . . . 3.5899999999999999 110.543 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . . . -58.68 124.0 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 1.3999999999999999 109.747 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.82 -27.8 9.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.091 -1.603 . . . . 1.1299999999999999 109.091 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.89 155.73 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -1.054 . . . . 1.8 110.79 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.27 158.68 2.98 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.641 0.734 . . . . 1.23 111.819 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 36.5 t -174.26 152.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.56000000000000005 110.923 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.9 m-20 -107.6 178.03 4.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.575 -0.703 . . . . 1.26 109.496 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.1 mp -77.69 -67.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 120.979 -1.076 . . . . 1.3799999999999999 108.906 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.6 p90 -63.87 -37.59 87.95 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.647 0.736 . . . . 1.75 109.535 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.635 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.1 t -96.51 95.51 8.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.856 0.836 . . . . 1.3400000000000001 109.718 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -86.55 140.47 29.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.156 -0.965 . . . . 0.94999999999999996 110.447 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -98.25 -14.5 20.26 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.069 . . . . 1.0600000000000001 110.082 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 26' ' ' GLU . 64.8 m -89.57 108.18 19.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 0.56999999999999995 109.882 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -51.84 -42.89 62.94 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 1.1000000000000001 110.421 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.59 48.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.063 -0.655 . . . . 0.59999999999999998 110.009 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.64 131.03 3.72 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.828 -1.177 . . . . 0.70999999999999996 110.276 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.87 124.89 18.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.521 -0.988 . . . . 1.6899999999999999 109.761 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.91 17.21 11.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.68999999999999995 112.958 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.4 -59.38 0.07 Allowed 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 118.725 0.693 . . . . 1.1699999999999999 111.941 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 2.7 m-85 -136.65 13.78 3.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.526 -0.734 . . . . 1.76 110.602 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.36 146.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 121.301 -0.874 . . . . 1.0900000000000001 109.726 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -95.92 127.35 41.86 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.255 -0.903 . . . . 0.75 111.396 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 3.1 mt -123.95 55.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 1.1699999999999999 110.321 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.183 ' HG2' ' N ' ' A' ' 27' ' ' NH2 . 17.9 tt0 -122.3 -126.91 0.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.003 -1.061 . . . . 1.2 110.286 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . 1.183 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.38 1.893 0 O-C-N 119.325 -2.109 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 120.98 0.419 . . . . 0.48999999999999999 110.128 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -142.35 -160.94 1.16 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.481 -0.762 . . . . 0.70999999999999996 110.816 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.4 mt-30 -79.19 154.13 29.49 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.347 -0.845 . . . . 0.95999999999999996 111.777 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.35 142.57 54.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.485 -0.76 . . . . 0.51000000000000001 111.042 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.43 -13.54 66.24 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 120.486 -0.864 . . . . 0.44 111.023 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 3.3 mt-10 -73.61 -178.79 3.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.291 . . . . 0.47999999999999998 110.781 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -66.01 151.13 47.5 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.268 -0.895 . . . . 0.80000000000000004 110.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 21.9 t -170.44 155.32 5.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.155 -0.966 . . . . 0.38 110.925 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -111.39 -171.33 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.62 -0.675 . . . . 0.64000000000000001 109.859 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.5 mp -83.84 -70.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.228 -0.92 . . . . 0.68999999999999995 108.649 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.4 p90 -60.86 -36.74 79.95 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.839 0.828 . . . . 0.68000000000000005 109.363 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.1 t -96.81 104.1 16.07 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.306 -0.627 . . . . 0.55000000000000004 109.306 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.536 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 1.5 mm-40 -98.86 144.59 27.89 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.035 -1.041 . . . . 0.40999999999999998 111.154 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 2.9 t-20 -108.61 -4.58 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.086 -1.009 . . . . 0.56000000000000005 110.72 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 22.0 m -90.07 103.66 16.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.118 -0.989 . . . . 0.33000000000000002 109.515 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.5 m -50.17 -31.38 13.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.51 -0.744 . . . . 0.48999999999999999 110.721 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.42 48.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.527 -0.733 . . . . 0.71999999999999997 110.714 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.65 147.27 16.19 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.8 -1.19 . . . . 0.42999999999999999 110.699 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.0 48.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -1.024 . . . . 1.05 109.855 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -118.42 9.95 12.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.153 -0.967 . . . . 0.42999999999999999 112.156 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -19.19 -63.29 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 118.516 0.598 . . . . 0.66000000000000003 112.284 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.436 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.36 3.93 4.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.569 -0.707 . . . . 1.4099999999999999 110.71 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.996 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -165.11 144.43 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.311 -0.868 . . . . 0.56000000000000005 108.991 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.703 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 4.2 t -77.42 88.61 3.79 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.085 -1.01 . . . . 0.45000000000000001 110.956 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.996 HD11 HD12 ' A' ' 23' ' ' ILE . 8.4 mt -106.35 114.99 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 1.3700000000000001 109.824 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -114.89 169.17 9.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.874 . . . . 1.25 110.755 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.927 0 O-C-N 119.348 -2.095 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 120.755 0.312 . . . . 1.1399999999999999 110.204 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -130.44 174.22 10.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.421 -0.8 . . . . 0.67000000000000004 110.151 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.68 151.34 30.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.198 -0.939 . . . . 1.4299999999999999 110.693 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . . . -58.78 126.98 29.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 0.94999999999999996 110.012 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.27 7.53 72.49 Favored Glycine 0 N--CA 1.498 2.802 0 C-N-CA 120.291 -0.957 . . . . 0.91000000000000003 110.846 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -85.91 -62.73 1.46 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.0 -1.294 . . . . 0.93000000000000005 110.232 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -173.15 144.61 1.24 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.345 -0.847 . . . . 1.1000000000000001 110.65 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 35.6 t -172.8 155.15 3.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.376 -0.827 . . . . 0.53000000000000003 110.256 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -110.63 -178.59 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.714 . . . . 0.88 110.223 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.5 mp -79.42 -64.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.254 -0.904 . . . . 0.89000000000000001 108.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.7 p90 -67.72 -37.82 82.73 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.782 0.801 . . . . 0.93000000000000005 109.213 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.6 t -94.32 89.16 5.8 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.722 0.772 . . . . 0.72999999999999998 109.688 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -84.98 139.01 32.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.282 -0.886 . . . . 0.58999999999999997 109.916 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 4.5 m-80 -126.99 15.29 7.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.966 -1.083 . . . . 0.88 112.187 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -78.23 104.96 9.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.858 -1.151 . . . . 0.90000000000000002 108.784 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m -46.59 -38.35 9.42 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.459 -0.776 . . . . 1.3500000000000001 111.271 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.631 HG23 ' HG3' ' A' ' 26' ' ' GLU . 5.8 m -141.57 50.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.769 -0.582 . . . . 1.6599999999999999 110.246 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.72 168.32 38.93 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 119.582 -1.294 . . . . 1.0800000000000001 111.142 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -80.93 160.67 24.61 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.497 -1.002 . . . . 0.83999999999999997 110.214 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -138.49 20.07 2.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.025 -1.047 . . . . 0.34999999999999998 112.756 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.42 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 118.967 0.803 . . . . 0.56999999999999995 111.774 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.1 10.76 3.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.54 -0.725 . . . . 1.77 110.57 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -170.86 147.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 O-C-N 121.3 -0.875 . . . . 1.49 109.214 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 51.6 t -95.2 107.03 19.1 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.831 -1.168 . . . . 0.76000000000000001 110.76 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.569 HD11 HD12 ' A' ' 23' ' ' ILE . 19.3 mt -118.99 100.92 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.722 -0.611 . . . . 1.55 109.532 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -79.24 147.42 32.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.42 -0.8 . . . . 2.2999999999999998 110.639 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.914 0 O-C-N 119.275 -2.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 109.986 -0.375 . . . . 0.48999999999999999 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.82 ' HE2' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -174.95 -173.8 0.72 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.416 -0.802 . . . . 0.48999999999999999 111.128 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.557 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -85.88 169.65 13.1 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.115 -0.99 . . . . 0.88 110.729 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.98 135.01 51.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.806 -1.184 . . . . 0.48999999999999999 109.499 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.63 52.03 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.384 -1.087 . . . . 0.39000000000000001 110.384 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.26 169.6 3.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -1.158 . . . . 0.57999999999999996 111.053 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.08 160.51 26.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.214 -0.929 . . . . 0.41999999999999998 111.247 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.555 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 1.7 t 176.85 156.25 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.449 -0.782 . . . . 0.34999999999999998 110.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -111.23 -176.56 2.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.854 . . . . 0.69999999999999996 110.156 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.5 mp -78.35 -67.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.271 -0.893 . . . . 0.54000000000000004 108.654 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.0 p90 -64.17 -35.99 82.6 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.723 0.773 . . . . 0.57999999999999996 109.371 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.5 t -98.67 95.62 7.38 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.588 0.709 . . . . 0.56999999999999995 109.204 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.555 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -92.98 144.21 25.48 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.121 -0.987 . . . . 0.42999999999999999 111.208 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -109.17 1.7 20.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.224 -0.922 . . . . 0.52000000000000002 110.49 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.046 -1.034 . . . . 0.75 108.764 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.0 m -53.55 -28.42 31.52 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.043 -1.035 . . . . 0.57999999999999996 111.85 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 47.11 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 1.0 110.665 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -161.97 153.0 23.57 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.155 -1.178 . . . . 0.48999999999999999 110.155 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.65 147.07 41.88 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -1.079 . . . . 0.83999999999999997 110.176 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -129.77 24.41 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.014 -1.054 . . . . 0.46999999999999997 112.291 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.37 -58.1 0.05 Allowed 'General case' 0 N--CA 1.513 2.714 0 CA-C-N 118.624 0.647 . . . . 0.52000000000000002 111.312 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.77 11.23 2.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 1.03 110.761 178.238 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -169.25 148.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 121.263 -0.898 . . . . 0.51000000000000001 109.628 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.82 ' SG ' ' HE2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -88.44 100.23 12.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.115 -0.99 . . . . 0.44 111.321 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.728 HD11 HD12 ' A' ' 23' ' ' ILE . 25.0 mt -117.5 118.94 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 1.1200000000000001 109.715 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.467 ' OE1' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -106.33 136.82 45.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.365 -0.834 . . . . 1.1200000000000001 110.316 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 1.944 0 O-C-N 119.438 -2.039 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 75.6 m . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.009 0.433 . . . . 2.1400000000000001 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 13.0 mttt -125.12 161.77 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 1.8500000000000001 110.422 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.3 mm100 -69.95 167.57 17.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.401 -0.812 . . . . 1.99 111.411 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -65.73 116.76 7.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.292 -0.88 . . . . 1.04 110.181 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.24 -3.72 69.79 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 120.18 -1.01 . . . . 1.6599999999999999 110.742 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -66.98 -68.86 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.078 -1.248 . . . . 2.0800000000000001 110.266 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m 176.16 149.91 0.13 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.548 -0.72 . . . . 1.9099999999999999 109.845 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -176.89 156.67 1.37 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.324 -0.86 . . . . 1.0600000000000001 110.273 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -110.52 179.96 3.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.442 -0.786 . . . . 1.3700000000000001 110.152 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.7 mp -79.9 -68.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.03 -1.043 . . . . 1.6299999999999999 108.871 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.1 p90 -61.41 -36.22 79.71 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.763 0.792 . . . . 1.3200000000000001 109.289 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -99.27 95.39 7.04 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.623 0.725 . . . . 0.83999999999999997 109.52 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -89.16 137.49 32.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.033 -1.042 . . . . 0.96999999999999997 109.982 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -116.37 33.64 5.44 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.996 -1.065 . . . . 1.46 111.37 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.24 100.53 10.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.884 -1.135 . . . . 1.27 109.815 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -36.37 8.34 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.643 -0.661 . . . . 2.25 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.5 53.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.065 -0.654 . . . . 2.2200000000000002 110.884 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.96 165.47 38.81 Favored Glycine 0 N--CA 1.505 3.249 0 C-N-CA 119.751 -1.214 . . . . 1.3999999999999999 111.228 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -82.32 168.91 17.08 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.376 -1.073 . . . . 1.9299999999999999 110.137 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -150.45 27.06 0.75 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.732 -1.23 . . . . 0.90000000000000002 113.481 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.36 -58.33 0.06 Allowed 'General case' 0 N--CA 1.517 2.914 0 CA-C-N 119.214 0.916 . . . . 1.6200000000000001 111.948 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -140.28 17.22 2.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.397 -0.814 . . . . 2.6000000000000001 110.731 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.0 149.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 O-C-N 121.488 -0.758 . . . . 1.55 109.726 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -103.9 134.18 47.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.085 -1.009 . . . . 0.81999999999999995 110.654 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 25' ' ' ILE . 3.3 mt -124.04 61.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.562 -0.711 . . . . 1.1699999999999999 110.005 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.08 139.92 48.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.086 -1.009 . . . . 1.4299999999999999 110.451 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.934 0 O-C-N 119.343 -2.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 1.2 m . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.144 0.497 . . . . 0.56000000000000005 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -145.16 136.79 25.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.65000000000000002 110.247 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 171.76 3.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 2.1200000000000001 110.521 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -63.18 110.21 1.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.175 -0.953 . . . . 0.40000000000000002 110.553 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.7 61.95 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.768 -0.933 . . . . 0.46999999999999997 110.768 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' OE2' ' HG3' ' A' ' 2' ' ' LYS . 8.4 tt0 -72.1 -62.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.279 . . . . 0.58999999999999997 109.792 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.9 OUTLIER 178.39 157.22 0.45 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.654 . . . . 0.97999999999999998 109.916 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.0 t -179.28 143.61 0.21 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.228 -0.92 . . . . 0.44 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.701 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 5.2 m-20 -105.3 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.149 -0.686 . . . . 0.75 109.149 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.2 mp -79.45 -64.67 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 0.54000000000000004 108.477 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -65.15 -36.61 84.79 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.723 0.773 . . . . 0.45000000000000001 109.355 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.701 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.9 t -96.46 95.28 7.91 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.882 0.849 . . . . 0.56999999999999995 110.054 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -90.45 134.14 34.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.184 -0.947 . . . . 0.54000000000000004 109.345 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 2.2 m-80 -113.64 23.16 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.767 -1.208 . . . . 0.58999999999999997 112.062 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 73.7 m -87.87 97.85 11.15 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.726 -1.234 . . . . 0.37 109.556 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -45.5 -38.5 6.32 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.478 -0.764 . . . . 0.77000000000000002 110.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.87 51.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 120.316 -0.553 . . . . 0.63 110.819 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -166.56 174.77 42.01 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 119.91 -1.138 . . . . 0.35999999999999999 110.735 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -88.22 155.88 19.52 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.353 -1.086 . . . . 0.59999999999999998 109.956 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -140.56 28.36 2.01 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.889 -1.132 . . . . 0.28000000000000003 112.513 -178.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -23.6 -60.18 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 O-C-N 121.686 -0.633 . . . . 0.42999999999999999 111.827 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.82 16.56 2.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.563 -0.711 . . . . 1.1699999999999999 110.18 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.78 152.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 O-C-N 121.534 -0.729 . . . . 0.85999999999999999 109.472 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 8.0 t -105.6 139.51 40.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.753 -1.217 . . . . 0.26000000000000001 110.983 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.449 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.9 mt -133.08 64.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.635 0.731 . . . . 0.80000000000000004 109.521 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.93 109.76 7.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 1.45 110.845 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.864 0 O-C-N 119.293 -2.13 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.109 0.48 . . . . 0.91000000000000003 109.85 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -130.11 135.63 48.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.551 -0.718 . . . . 0.94999999999999996 109.757 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -53.43 155.33 2.95 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.512 -0.742 . . . . 2.0499999999999998 111.558 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 25' ' ' ILE . . . -52.48 129.82 29.9 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.321 -0.862 . . . . 0.90000000000000002 110.88 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.23 -26.14 19.68 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.92 -1.272 . . . . 0.73999999999999999 109.92 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 2.5 mm-40 -65.06 169.7 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -1.077 . . . . 1.5700000000000001 110.685 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.508 ' OG ' ' NZ ' ' A' ' 2' ' ' LYS . 1.6 p -59.14 158.0 9.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.398 -0.814 . . . . 0.64000000000000001 111.623 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -178.44 138.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.57999999999999996 109.921 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -105.73 179.01 4.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.536 -0.728 . . . . 0.81000000000000005 109.53 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.6 mp -74.06 -65.67 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.188 -0.945 . . . . 1.21 108.721 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.55 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.9 p90 -67.46 -38.39 84.38 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.743 0.782 . . . . 1.3200000000000001 109.253 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.671 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -95.05 91.1 6.18 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.771 0.796 . . . . 1.04 109.2 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -87.28 132.49 33.9 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.058 -1.026 . . . . 0.88 109.976 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' OD1' ' HE3' ' A' ' 2' ' ' LYS . 2.2 m-80 -96.19 2.82 53.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.839 -1.163 . . . . 1.1200000000000001 110.73 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 38.8 m -101.83 103.24 13.93 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.238 -0.914 . . . . 0.46000000000000002 109.849 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 96.4 m -52.24 -33.56 42.06 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.47 -0.769 . . . . 0.81000000000000005 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 17' ' ' VAL . 7.8 p -137.93 45.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.766 0.793 . . . . 0.56999999999999995 110.217 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.1 137.94 6.78 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.094 -1.202 . . . . 0.46999999999999997 110.094 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.95 133.31 51.5 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.54 -0.976 . . . . 1.3300000000000001 109.601 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -125.74 11.54 7.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.925 -1.109 . . . . 0.64000000000000001 112.941 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.25 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 118.701 0.682 . . . . 1.04 112.304 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -135.09 10.2 3.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.405 -0.809 . . . . 1.77 110.832 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.01 156.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 121.183 -0.948 . . . . 0.88 109.655 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -100.35 127.65 46.61 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.006 -1.059 . . . . 0.52000000000000002 111.394 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.427 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.6 mp -124.5 57.04 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.628 -0.67 . . . . 1.1599999999999999 110.088 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 2.7 tt0 -87.35 111.31 20.95 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.985 -1.072 . . . . 1.51 110.722 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.929 0 O-C-N 119.282 -2.136 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 3.4 mtpp -136.2 -173.31 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.444 -0.785 . . . . 0.72999999999999998 110.583 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 4.3 mt-30 -80.28 150.5 29.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.242 -0.911 . . . . 0.95999999999999996 111.37 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . . . -62.33 126.5 27.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.323 -0.861 . . . . 0.72999999999999998 110.352 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.46 3.13 82.17 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.768 -0.933 . . . . 0.67000000000000004 110.768 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 3' ' ' GLN . 2.3 tt0 -83.29 -63.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.192 -1.181 . . . . 0.60999999999999999 110.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 1.6 m -173.17 151.21 2.04 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.363 -0.836 . . . . 0.40000000000000002 110.393 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 51.1 t -167.16 158.16 11.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.237 -0.915 . . . . 0.34999999999999998 110.552 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.623 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.3 OUTLIER -109.04 179.88 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.582 -0.698 . . . . 0.45000000000000001 109.566 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 21' ' ' ALA . 1.3 mp -85.13 -69.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.971 -1.08 . . . . 0.51000000000000001 108.779 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.2 p90 -60.22 -38.23 82.75 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.827 0.822 . . . . 0.39000000000000001 109.133 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.623 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -94.04 102.42 14.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.559 0.695 . . . . 0.34000000000000002 109.96 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -88.02 131.16 34.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.196 -0.94 . . . . 0.44 109.678 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 4.3 m-80 -118.84 23.56 11.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.786 -1.197 . . . . 0.69999999999999996 112.037 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -95.33 101.95 13.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.913 -1.117 . . . . 0.60999999999999999 109.267 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.94 -37.36 8.88 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.549 -0.719 . . . . 1.26 111.533 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.502 HG23 ' HG3' ' A' ' 26' ' ' GLU . 16.4 m -141.34 52.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 119.614 -0.835 . . . . 1.0800000000000001 110.364 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -166.31 164.66 37.74 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.736 -1.221 . . . . 0.55000000000000004 110.972 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.56 157.99 33.12 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.448 -1.031 . . . . 1.1100000000000001 109.708 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -139.61 19.02 2.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.707 -1.245 . . . . 0.34999999999999998 113.527 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -22.83 -59.8 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 CA-C-N 119.367 0.985 . . . . 0.44 111.743 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' C ' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -140.61 14.95 2.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.661 -0.649 . . . . 1.0 110.124 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.57 140.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.319 -0.863 . . . . 0.66000000000000003 109.399 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.1 t -94.32 110.42 22.18 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.716 -1.24 . . . . 0.46999999999999997 110.547 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.457 HD11 HD12 ' A' ' 23' ' ' ILE . 13.6 mt -122.3 135.52 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.572 . . . . 1.29 109.472 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -103.35 160.34 14.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 3.5 110.475 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.926 0 O-C-N 119.423 -2.048 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.912 -0.403 . . . . 1.49 109.912 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.495 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 13.9 mttt -156.27 124.68 5.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.754 -0.591 . . . . 0.90000000000000002 109.875 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 -57.96 155.88 10.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.443 -0.786 . . . . 1.49 110.806 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -54.88 123.0 12.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -0.827 . . . . 1.1299999999999999 110.95 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.67 61.65 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 120.376 -0.916 . . . . 1.1399999999999999 111.676 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -67.16 -74.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.064 1.432 . . . . 1.0900000000000001 110.736 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -176.12 155.52 1.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.02 -1.05 . . . . 0.68999999999999995 110.234 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 39.6 t 179.73 153.22 0.47 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.974 . . . . 0.62 111.617 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.65 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -112.53 -178.37 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.727 -0.842 . . . . 0.77000000000000002 108.727 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.83 -68.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.781 -1.199 . . . . 1.3100000000000001 108.723 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.8 p90 -62.09 -36.79 82.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.676 0.75 . . . . 1.25 109.686 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -96.03 96.67 9.03 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.653 0.74 . . . . 0.84999999999999998 110.141 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -86.31 135.07 33.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.103 -0.998 . . . . 0.82999999999999996 109.71 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.5 m-80 -101.67 -11.96 18.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.87 -1.144 . . . . 0.77000000000000002 110.861 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 55.0 m -85.6 103.73 14.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.26 -0.9 . . . . 0.84999999999999998 109.906 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.2 m -50.16 -36.84 31.86 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.378 -0.826 . . . . 1.27 110.36 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.88 51.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 120.071 -0.652 . . . . 1.55 110.614 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.32 142.56 9.03 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.547 -1.311 . . . . 0.89000000000000001 110.783 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.12 129.87 43.51 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -1.043 . . . . 0.81999999999999995 109.402 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.36 14.49 12.05 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.521 -0.872 . . . . 0.54000000000000004 113.285 -178.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.02 -63.32 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 118.633 0.651 . . . . 0.89000000000000001 112.497 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.425 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.49 12.85 3.23 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.806 . . . . 1.74 110.794 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.87 156.59 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 0.81000000000000005 109.251 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -106.97 127.85 53.82 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.01 -1.056 . . . . 0.56999999999999995 111.476 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.55 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.6 mt -123.2 54.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.556 0.693 . . . . 0.78000000000000003 109.864 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.997 ' HG2' ' N ' ' A' ' 27' ' ' NH2 . 17.8 tt0 -108.88 -146.08 0.4 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 1.1799999999999999 110.631 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . 0.997 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.38 1.904 0 O-C-N 119.194 -2.191 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 35.0 m . . . . . 0 N--CA 1.501 2.093 0 N-CA-C 109.724 -0.473 . . . . 1.21 109.724 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -154.49 121.49 5.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.702 . . . . 0.44 110.481 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.61 148.2 16.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.547 -0.72 . . . . 1.48 110.91 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 25' ' ' ILE . . . -49.94 128.85 19.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.407 -0.808 . . . . 0.58999999999999997 110.598 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.19 -32.74 6.77 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.853 -1.299 . . . . 0.54000000000000004 109.853 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -59.87 157.32 12.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -1.131 . . . . 0.48999999999999999 111.059 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -52.07 156.21 1.65 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.556 0.693 . . . . 0.90000000000000002 111.95 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 42.7 t -170.19 148.35 3.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.491 -0.756 . . . . 0.47999999999999998 110.829 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.659 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.8 m-20 -104.33 175.96 5.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.827 . . . . 0.63 109.865 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.4 mp -78.12 -71.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.069 -1.02 . . . . 0.90000000000000002 108.973 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -58.36 -36.92 74.2 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.702 0.763 . . . . 0.93000000000000005 109.602 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.659 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.2 t -97.21 97.21 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.758 0.79 . . . . 0.65000000000000002 109.765 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.32 145.15 32.26 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.158 -0.964 . . . . 0.62 110.359 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 1.9 m-80 -103.17 -16.41 15.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.965 -1.085 . . . . 0.44 110.552 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . 2.3 m -81.13 107.69 14.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.139 -0.976 . . . . 0.41999999999999998 109.653 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -49.5 -37.83 28.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.249 -0.907 . . . . 0.73999999999999999 109.991 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.82 52.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 120.184 -0.607 . . . . 0.91000000000000003 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -159.01 155.43 26.5 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.424 -1.369 . . . . 0.46000000000000002 110.951 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 t -71.76 148.51 46.25 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.417 -1.049 . . . . 0.5 109.903 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -142.73 24.61 1.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.082 -1.011 . . . . 0.38 112.537 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.39 -58.15 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 118.706 0.685 . . . . 0.60999999999999999 111.993 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.2 15.1 2.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.47 -0.769 . . . . 1.5800000000000001 110.691 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.77 147.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 O-C-N 121.374 -0.829 . . . . 0.62 109.276 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.0 t -100.74 138.33 37.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.076 -1.015 . . . . 0.34000000000000002 112.318 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.556 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.4 mp -128.75 54.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.645 0.736 . . . . 0.69999999999999996 109.368 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 19.8 tt0 -99.15 175.81 5.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.235 -0.916 . . . . 0.62 110.786 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . 0.475 ' N ' ' CG ' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.381 1.943 0 O-C-N 119.169 -2.207 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 120.941 0.401 . . . . 1.95 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -151.31 175.91 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.717 -0.614 . . . . 1.54 110.159 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -78.68 144.51 35.27 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 1.6100000000000001 111.197 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.56 126.99 29.5 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.316 -0.865 . . . . 1.3100000000000001 110.078 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.92 -2.82 67.26 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.818 -0.913 . . . . 1.74 110.818 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.78 -63.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.984 -1.304 . . . . 1.8500000000000001 110.687 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 79.7 p -164.21 165.26 22.18 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.249 -0.907 . . . . 1.26 110.429 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 25.8 t -178.62 145.8 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.146 -0.971 . . . . 0.68000000000000005 111.826 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.666 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.2 m-20 -110.77 174.86 5.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.76000000000000001 108.599 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.2 mp -81.22 -70.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.924 -1.11 . . . . 1.55 108.771 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 12' ' ' SER . 32.1 p90 -58.92 -36.0 74.01 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.696 0.76 . . . . 1.48 109.404 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.666 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.3 t -97.67 95.93 7.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.577 0.703 . . . . 1.01 110.072 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -74.53 132.98 42.3 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.12 -0.988 . . . . 1.3600000000000001 109.775 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . 2.4 m-80 -96.14 -37.4 10.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.128 . . . . 0.97999999999999998 111.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 m -53.75 113.51 1.22 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.17 -0.956 . . . . 1.2 110.025 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.0 m -45.69 -40.67 9.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.371 -0.831 . . . . 1.8100000000000001 110.741 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -144.27 47.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.31 0.576 . . . . 2.0099999999999998 109.853 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.75 157.91 27.51 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.566 -1.302 . . . . 1.22 110.806 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -64.21 150.32 46.09 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.956 . . . . 1.79 109.667 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -147.3 25.26 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.156 -1.018 . . . . 1.1899999999999999 112.859 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.71 -59.86 0.09 Allowed 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 118.973 0.806 . . . . 1.8500000000000001 111.376 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -138.66 17.04 2.7 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.626 -0.671 . . . . 2.25 110.346 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -171.55 144.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 O-C-N 121.193 -0.942 . . . . 1.8700000000000001 109.979 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.5 t -99.35 112.52 24.68 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.945 -1.097 . . . . 0.69999999999999996 110.482 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 25' ' ' ILE . 1.6 tt -114.01 58.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.919 0.866 . . . . 1.49 110.346 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.79 134.75 57.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.131 -0.981 . . . . 1.0 110.73 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.911 0 O-C-N 119.342 -2.099 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 120.926 0.393 . . . . 1.0800000000000001 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -123.49 153.02 41.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.505 -0.747 . . . . 1.03 110.091 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.72 31.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.186 -0.946 . . . . 1.1899999999999999 110.226 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.73 123.1 15.25 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 0.70999999999999996 109.665 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.92 2.77 90.5 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.297 -0.954 . . . . 0.75 111.03 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.615 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 4.6 tt0 -76.79 -69.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.942 -1.328 . . . . 1.05 110.085 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.4 148.04 4.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.205 -0.935 . . . . 0.84999999999999998 110.42 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -173.74 148.09 1.44 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.752 . . . . 0.72999999999999998 110.119 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -109.85 -176.25 2.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 1.3799999999999999 109.576 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.4 mp -79.82 -65.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 1.1100000000000001 108.711 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.5 p90 -65.36 -37.14 86.13 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.707 0.765 . . . . 1.1499999999999999 109.198 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.667 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.7 t -94.29 95.54 8.98 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.715 0.769 . . . . 1.01 109.742 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.7 129.41 36.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.298 -0.876 . . . . 0.58999999999999997 109.847 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.693 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -118.89 19.06 13.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.15 -0.969 . . . . 0.93999999999999995 111.724 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.698 ' SG ' ' HG3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -93.13 90.47 6.89 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.174 -0.954 . . . . 0.57999999999999996 109.678 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.7 m -53.45 -32.97 52.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.449 -0.782 . . . . 0.94999999999999996 111.43 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.1 48.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.288 -0.883 . . . . 1.46 111.307 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . 179.36 171.97 43.02 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.55 -1.31 . . . . 0.57999999999999996 111.066 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -80.65 165.45 22.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.415 -1.05 . . . . 0.67000000000000004 109.669 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -142.3 19.17 2.07 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.689 -1.257 . . . . 0.32000000000000001 113.376 -178.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.13 -60.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.256 0.934 . . . . 0.55000000000000004 111.63 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.78 13.22 2.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 1.29 110.466 178.713 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.39 149.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 O-C-N 121.416 -0.803 . . . . 0.75 109.398 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 11.1 t -99.02 112.93 24.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.992 -1.068 . . . . 0.55000000000000004 110.631 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 23' ' ' ILE . 33.3 mt -125.42 88.58 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.551 -0.718 . . . . 1.3700000000000001 109.409 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.698 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 71.7 mt-10 -80.55 154.22 27.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 1.5600000000000001 110.832 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.92 0 O-C-N 119.227 -2.17 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.868 -0.419 . . . . 1.03 109.868 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -133.03 175.6 9.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.455 -0.778 . . . . 1.9299999999999999 110.541 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 2.1 tt0 -80.98 150.24 29.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 1.6000000000000001 110.581 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' N ' ' HG2' ' A' ' 3' ' ' GLN . . . -60.71 131.44 50.71 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 1.26 110.133 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.8 70.98 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.491 -0.862 . . . . 0.82999999999999996 111.029 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 3' ' ' GLN . 3.4 tt0 -83.19 -66.64 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.957 -1.319 . . . . 0.96999999999999997 110.941 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -171.9 146.1 1.98 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.169 -0.957 . . . . 0.5 110.733 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.636 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 41.2 t -170.68 154.42 4.45 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.271 -0.893 . . . . 0.5 110.956 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.611 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 3.3 m-20 -104.52 -173.51 2.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.705 -0.622 . . . . 0.68999999999999995 109.898 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.1 mp -88.53 -66.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.211 -0.93 . . . . 0.89000000000000001 108.56 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -64.83 -36.85 85.65 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.863 0.84 . . . . 0.93999999999999995 109.005 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.611 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.2 t -94.05 93.65 7.97 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.716 0.77 . . . . 0.68000000000000005 109.574 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -86.53 133.66 33.72 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.099 -1.001 . . . . 0.54000000000000004 109.885 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 1.9 m-80 -117.78 12.21 13.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.892 -1.13 . . . . 0.73999999999999999 111.901 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.71 106.48 8.4 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.936 -1.102 . . . . 0.72999999999999998 109.323 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.4 m -44.36 -31.5 1.06 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.586 -0.696 . . . . 0.81999999999999995 111.302 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.0 p -156.25 49.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.807 0.813 . . . . 0.60999999999999999 109.957 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.23 168.67 34.14 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.568 -1.301 . . . . 0.59999999999999998 111.15 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.42 150.57 33.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.574 -0.957 . . . . 1.5900000000000001 110.043 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -132.91 15.97 4.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.911 -1.118 . . . . 0.56000000000000005 112.973 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.08 -63.53 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 118.902 0.774 . . . . 0.79000000000000004 111.974 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.04 11.3 3.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 1.6899999999999999 110.291 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -169.18 143.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.463 -0.773 . . . . 1.03 108.961 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 49.3 t -95.71 114.02 25.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.798 -1.189 . . . . 0.63 110.705 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 25' ' ' ILE . 1.4 tp -129.08 124.46 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.402 0.62 . . . . 1.26 110.137 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 153.06 30.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.3500000000000001 110.342 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.891 0 O-C-N 119.361 -2.087 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 109.65 -0.5 . . . . 0.44 109.65 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.36 125.52 5.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.657 -0.652 . . . . 0.46000000000000002 110.082 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 10.0 mp0 -51.11 149.28 3.83 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.552 0.691 . . . . 1.29 111.446 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 25' ' ' ILE . . . -50.23 132.28 24.01 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.502 -0.749 . . . . 0.37 110.708 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.15 -35.22 5.19 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.643 -1.383 . . . . 0.33000000000000002 109.643 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -55.16 151.18 9.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.505 -0.997 . . . . 0.79000000000000004 111.098 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.28 157.36 0.48 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.464 0.649 . . . . 0.67000000000000004 111.558 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.409 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 41.0 t -170.52 149.31 3.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.251 -0.905 . . . . 0.33000000000000002 110.914 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.646 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.4 m-20 -102.3 -179.23 3.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 0.52000000000000002 109.586 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.08 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.057 -1.027 . . . . 0.59999999999999998 108.793 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.6 p90 -57.19 -38.14 73.23 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.739 0.78 . . . . 0.54000000000000004 109.307 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.0 t -94.37 98.66 11.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.714 0.768 . . . . 0.42999999999999999 109.647 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.62 140.69 33.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.317 -0.864 . . . . 0.51000000000000001 110.357 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.0 m-80 -96.65 -19.75 18.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.066 -1.021 . . . . 0.38 110.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.9 m -79.23 111.47 15.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.129 -0.982 . . . . 0.26000000000000001 109.698 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.31 -35.61 8.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.358 -0.839 . . . . 0.41999999999999998 109.928 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 17' ' ' VAL . 14.5 p -142.71 52.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.535 0.683 . . . . 0.52000000000000002 110.2 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.3 151.42 23.47 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.461 -1.352 . . . . 0.28000000000000003 110.964 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.28 124.85 24.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.476 -1.014 . . . . 0.77000000000000002 109.589 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -123.76 23.34 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.207 -0.933 . . . . 0.27000000000000002 112.472 -178.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.51 -56.96 0.08 Allowed 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.628 -0.67 . . . . 0.40000000000000002 112.084 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -139.23 15.74 2.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.437 -0.79 . . . . 1.3999999999999999 110.405 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.29 145.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.493 -0.754 . . . . 0.66000000000000003 109.345 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 29.1 t -99.15 136.46 39.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.27000000000000002 111.726 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.589 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 3.8 mt -126.78 53.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.536 0.684 . . . . 0.88 109.553 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 2' ' ' LYS . 3.2 tt0 -84.11 127.27 33.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.979 -1.076 . . . . 0.51000000000000001 110.481 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.873 0 O-C-N 119.419 -2.051 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 26.1 t . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 110.001 -0.37 . . . . 0.54000000000000004 110.001 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HG2' ' CD ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -149.87 -174.29 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.555 -0.716 . . . . 0.71999999999999997 110.549 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 6.4 tp-100 -79.67 152.69 29.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.767 . . . . 1.1499999999999999 110.559 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . . . -57.41 133.69 55.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.367 -0.833 . . . . 0.40000000000000002 110.121 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.65 -14.22 64.41 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.571 -1.012 . . . . 0.34000000000000002 110.571 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -77.06 -170.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.278 . . . . 0.57999999999999996 110.681 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 146.99 52.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.169 -0.957 . . . . 1.0800000000000001 111.535 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.669 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 19.4 t -171.71 156.46 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.552 -0.717 . . . . 0.38 110.848 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 4.0 m-20 -113.64 -175.33 2.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.68 -0.637 . . . . 0.52000000000000002 109.915 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.0 mp -78.32 -66.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.296 -0.877 . . . . 0.56000000000000005 108.929 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -69.05 -38.14 78.93 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.745 0.783 . . . . 0.52000000000000002 109.387 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 5.1 t -94.94 95.85 8.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.807 -0.812 . . . . 0.5 108.807 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.669 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -96.01 150.19 20.74 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.215 -0.928 . . . . 0.45000000000000001 112.014 -177.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 1.4 m-20 -111.64 -1.33 15.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.443 -0.785 . . . . 0.48999999999999999 110.572 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 m -88.17 96.04 10.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.954 -1.091 . . . . 0.33000000000000002 109.783 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -55.11 -26.15 36.31 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.201 -0.937 . . . . 0.68999999999999995 110.933 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.45 46.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.203 -0.935 . . . . 0.75 110.802 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' HA3' ' HG3' ' A' ' 26' ' ' GLU . . . -171.55 165.0 37.89 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.411 -1.076 . . . . 0.77000000000000002 110.411 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -84.26 167.9 16.19 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.335 -1.097 . . . . 0.79000000000000004 110.382 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -143.17 24.81 1.78 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.271 -0.893 . . . . 0.68999999999999995 112.523 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -17.88 -66.75 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 118.582 0.628 . . . . 0.72999999999999998 111.95 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -131.14 6.47 4.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.539 -0.726 . . . . 1.6599999999999999 110.815 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.13 152.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.741 -0.837 . . . . 0.70999999999999996 108.741 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.623 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 30.1 t -86.15 118.04 25.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.45000000000000001 111.233 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 25' ' ' ILE . 1.3 tp -140.66 124.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.316 0.579 . . . . 1.3799999999999999 110.009 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HG3' ' HA3' ' A' ' 18' ' ' GLY . 2.3 mt-10 -122.14 -155.0 0.62 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.226 -0.921 . . . . 1.24 110.797 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.912 0 O-C-N 119.219 -2.176 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.091 -1.603 . . . . 1.13 109.091 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 155.73 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -1.054 . . . . 1.8 110.79 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.27 158.68 2.98 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.641 0.734 . . . . 1.23 111.819 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 36.5 t -174.26 152.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.56 110.923 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.9 m-20 -107.6 178.03 4.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.575 -0.703 . . . . 1.26 109.496 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.1 mp -77.69 -67.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 120.979 -1.076 . . . . 1.38 108.906 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.6 p90 -63.87 -37.59 87.95 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.647 0.736 . . . . 1.75 109.535 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.635 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.1 t -96.51 95.51 8.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.856 0.836 . . . . 1.34 109.718 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -86.55 140.47 29.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.156 -0.965 . . . . 0.95 110.447 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -98.25 -14.5 20.26 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.069 . . . . 1.06 110.082 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 64.8 m -89.57 108.18 19.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 0.57 109.882 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -51.84 -42.89 62.94 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 1.1 110.421 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.59 48.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.063 -0.655 . . . . 0.6 110.009 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.64 131.03 3.72 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.828 -1.177 . . . . 0.71 110.276 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.87 124.89 18.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.521 -0.988 . . . . 1.69 109.761 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.91 17.21 11.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.69 112.958 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.4 -59.38 0.07 Allowed 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 118.725 0.693 . . . . 1.17 111.941 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 2.7 m-85 -136.65 13.78 3.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.526 -0.734 . . . . 1.76 110.602 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.36 146.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 121.301 -0.874 . . . . 1.09 109.726 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -95.92 127.35 41.86 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.255 -0.903 . . . . 0.75 111.396 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 25' ' ' ILE . 3.1 mt . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 1.17 110.321 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . . . . . . 0 N--CA 1.5 2.955 0 N-CA-C 111.023 -0.831 . . . . 0.44 111.023 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -73.61 -178.79 3.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.291 . . . . 0.48 110.781 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -66.01 151.13 47.5 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.268 -0.895 . . . . 0.8 110.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 21.9 t -170.44 155.32 5.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.155 -0.966 . . . . 0.38 110.925 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -111.39 -171.33 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.62 -0.675 . . . . 0.64 109.859 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.5 mp -83.84 -70.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.228 -0.92 . . . . 0.69 108.649 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.4 p90 -60.86 -36.74 79.95 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.839 0.828 . . . . 0.68 109.363 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.1 t -96.81 104.1 16.07 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.306 -0.627 . . . . 0.55 109.306 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.536 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 1.5 mm-40 -98.86 144.59 27.89 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.035 -1.041 . . . . 0.41 111.154 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.61 -4.58 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.086 -1.009 . . . . 0.56 110.72 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 22.0 m -90.07 103.66 16.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.118 -0.989 . . . . 0.33 109.515 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.5 m -50.17 -31.38 13.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.51 -0.744 . . . . 0.49 110.721 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.42 48.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.527 -0.733 . . . . 0.72 110.714 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.65 147.27 16.19 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.8 -1.19 . . . . 0.43 110.699 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.0 48.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -1.024 . . . . 1.05 109.855 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -118.42 9.95 12.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.153 -0.967 . . . . 0.43 112.156 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -19.19 -63.29 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 118.516 0.598 . . . . 0.66 112.284 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.436 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.36 3.93 4.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.569 -0.707 . . . . 1.41 110.71 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.996 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -165.11 144.43 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.311 -0.868 . . . . 0.56 108.991 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.703 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 4.2 t -77.42 88.61 3.79 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.085 -1.01 . . . . 0.45 110.956 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.996 HD11 HD12 ' A' ' 23' ' ' ILE . 8.4 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 1.37 109.824 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.802 0 N-CA-C 110.846 -0.902 . . . . 0.91 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -85.91 -62.73 1.46 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.0 -1.294 . . . . 0.93 110.232 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -173.15 144.61 1.24 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.345 -0.847 . . . . 1.1 110.65 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 35.6 t -172.8 155.15 3.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.376 -0.827 . . . . 0.53 110.256 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -110.63 -178.59 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.714 . . . . 0.88 110.223 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.5 mp -79.42 -64.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.254 -0.904 . . . . 0.89 108.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.7 p90 -67.72 -37.82 82.73 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.782 0.801 . . . . 0.93 109.213 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.6 t -94.32 89.16 5.8 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.722 0.772 . . . . 0.73 109.688 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -84.98 139.01 32.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.282 -0.886 . . . . 0.59 109.916 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -126.99 15.29 7.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.966 -1.083 . . . . 0.88 112.187 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -78.23 104.96 9.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.858 -1.151 . . . . 0.9 108.784 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m -46.59 -38.35 9.42 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.459 -0.776 . . . . 1.35 111.271 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -141.57 50.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.769 -0.582 . . . . 1.66 110.246 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.72 168.32 38.93 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 119.582 -1.294 . . . . 1.08 111.142 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -80.93 160.67 24.61 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.497 -1.002 . . . . 0.84 110.214 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -138.49 20.07 2.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.025 -1.047 . . . . 0.35 112.756 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.42 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 118.967 0.803 . . . . 0.57 111.774 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.1 10.76 3.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.54 -0.725 . . . . 1.77 110.57 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -170.86 147.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 O-C-N 121.3 -0.875 . . . . 1.49 109.214 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 51.6 t -95.2 107.03 19.1 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.831 -1.168 . . . . 0.76 110.76 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.569 HD11 HD12 ' A' ' 23' ' ' ILE . 19.3 mt . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.722 -0.611 . . . . 1.55 109.532 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.737 0 N-CA-C 110.384 -1.087 . . . . 0.39 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.26 169.6 3.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -1.158 . . . . 0.58 111.053 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.08 160.51 26.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.214 -0.929 . . . . 0.42 111.247 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.555 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 1.7 t 176.85 156.25 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.449 -0.782 . . . . 0.35 110.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -111.23 -176.56 2.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.854 . . . . 0.7 110.156 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.5 mp -78.35 -67.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.271 -0.893 . . . . 0.54 108.654 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.0 p90 -64.17 -35.99 82.6 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.723 0.773 . . . . 0.58 109.371 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.5 t -98.67 95.62 7.38 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.588 0.709 . . . . 0.57 109.204 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.555 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -92.98 144.21 25.48 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.121 -0.987 . . . . 0.43 111.208 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -109.17 1.7 20.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.224 -0.922 . . . . 0.52 110.49 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.046 -1.034 . . . . 0.75 108.764 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.0 m -53.55 -28.42 31.52 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.043 -1.035 . . . . 0.58 111.85 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 47.11 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 1.0 110.665 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -161.97 153.0 23.57 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.155 -1.178 . . . . 0.49 110.155 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.65 147.07 41.88 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -1.079 . . . . 0.84 110.176 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -129.77 24.41 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.014 -1.054 . . . . 0.47 112.291 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.37 -58.1 0.05 Allowed 'General case' 0 N--CA 1.513 2.714 0 CA-C-N 118.624 0.647 . . . . 0.52 111.312 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.495 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.77 11.23 2.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 1.03 110.761 178.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -169.25 148.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 121.263 -0.898 . . . . 0.51 109.628 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -88.44 100.23 12.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.115 -0.99 . . . . 0.44 111.321 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.728 HD11 HD12 ' A' ' 23' ' ' ILE . 25.0 mt . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 1.12 109.715 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.851 0 N-CA-C 110.742 -0.943 . . . . 1.66 110.742 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -68.86 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.078 -1.248 . . . . 2.08 110.266 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m 176.16 149.91 0.13 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.548 -0.72 . . . . 1.91 109.845 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -176.89 156.67 1.37 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.324 -0.86 . . . . 1.06 110.273 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -110.52 179.96 3.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.442 -0.786 . . . . 1.37 110.152 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.537 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.7 mp -79.9 -68.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.03 -1.043 . . . . 1.63 108.871 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.1 p90 -61.41 -36.22 79.71 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.763 0.792 . . . . 1.32 109.289 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -99.27 95.39 7.04 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.623 0.725 . . . . 0.84 109.52 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -89.16 137.49 32.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.033 -1.042 . . . . 0.97 109.982 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.37 33.64 5.44 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.996 -1.065 . . . . 1.46 111.37 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.24 100.53 10.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.884 -1.135 . . . . 1.27 109.815 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -36.37 8.34 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.643 -0.661 . . . . 2.25 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.5 53.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.065 -0.654 . . . . 2.22 110.884 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.96 165.47 38.81 Favored Glycine 0 N--CA 1.505 3.249 0 C-N-CA 119.751 -1.214 . . . . 1.4 111.228 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -82.32 168.91 17.08 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.376 -1.073 . . . . 1.93 110.137 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -150.45 27.06 0.75 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.732 -1.23 . . . . 0.9 113.481 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.36 -58.33 0.06 Allowed 'General case' 0 N--CA 1.517 2.914 0 CA-C-N 119.214 0.916 . . . . 1.62 111.948 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -140.28 17.22 2.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.397 -0.814 . . . . 2.6 110.731 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.0 149.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 O-C-N 121.488 -0.758 . . . . 1.55 109.726 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -103.9 134.18 47.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.085 -1.009 . . . . 0.82 110.654 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 25' ' ' ILE . 3.3 mt . . . . . 0 N--CA 1.497 1.925 0 O-C-N 121.562 -0.711 . . . . 1.17 110.005 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 N-CA-C 110.768 -0.933 . . . . 0.47 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 7' ' ' SER . 8.4 tt0 -72.1 -62.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.279 . . . . 0.59 109.792 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.9 OUTLIER 178.39 157.22 0.45 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.654 . . . . 0.98 109.916 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.0 t -179.28 143.61 0.21 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.228 -0.92 . . . . 0.44 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.701 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 5.2 m-20 -105.3 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.149 -0.686 . . . . 0.75 109.149 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.2 mp -79.45 -64.67 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 0.54 108.477 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -65.15 -36.61 84.79 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.723 0.773 . . . . 0.45 109.355 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.701 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.9 t -96.46 95.28 7.91 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.882 0.849 . . . . 0.57 110.054 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -90.45 134.14 34.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.184 -0.947 . . . . 0.54 109.345 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -113.64 23.16 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.767 -1.208 . . . . 0.59 112.062 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 73.7 m -87.87 97.85 11.15 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.726 -1.234 . . . . 0.37 109.556 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -45.5 -38.5 6.32 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.478 -0.764 . . . . 0.77 110.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.87 51.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 120.316 -0.553 . . . . 0.63 110.819 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -166.56 174.77 42.01 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 119.91 -1.138 . . . . 0.36 110.735 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -88.22 155.88 19.52 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.353 -1.086 . . . . 0.6 109.956 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -140.56 28.36 2.01 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.889 -1.132 . . . . 0.28 112.513 -178.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -23.6 -60.18 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 O-C-N 121.686 -0.633 . . . . 0.43 111.827 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.82 16.56 2.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.563 -0.711 . . . . 1.17 110.18 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.78 152.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 O-C-N 121.534 -0.729 . . . . 0.86 109.472 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 8.0 t -105.6 139.51 40.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.753 -1.217 . . . . 0.26 110.983 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 121.635 0.731 . . . . 0.8 109.521 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.92 -1.272 . . . . 0.74 109.92 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.06 169.7 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -1.077 . . . . 1.57 110.685 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -59.14 158.0 9.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.398 -0.814 . . . . 0.64 111.623 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -178.44 138.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.58 109.921 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -105.73 179.01 4.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.536 -0.728 . . . . 0.81 109.53 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.6 mp -74.06 -65.67 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.188 -0.945 . . . . 1.21 108.721 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.55 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.9 p90 -67.46 -38.39 84.38 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.743 0.782 . . . . 1.32 109.253 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.671 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -95.05 91.1 6.18 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.771 0.796 . . . . 1.04 109.2 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -87.28 132.49 33.9 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.058 -1.026 . . . . 0.88 109.976 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -96.19 2.82 53.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.839 -1.163 . . . . 1.12 110.73 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.451 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.8 m -101.83 103.24 13.93 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.238 -0.914 . . . . 0.46 109.849 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 96.4 m -52.24 -33.56 42.06 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.47 -0.769 . . . . 0.81 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 17' ' ' VAL . 7.8 p -137.93 45.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.766 0.793 . . . . 0.57 110.217 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.1 137.94 6.78 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.094 -1.202 . . . . 0.47 110.094 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.95 133.31 51.5 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.54 -0.976 . . . . 1.33 109.601 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -125.74 11.54 7.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.925 -1.109 . . . . 0.64 112.941 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.25 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 118.701 0.682 . . . . 1.04 112.304 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -135.09 10.2 3.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.405 -0.809 . . . . 1.77 110.832 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.01 156.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 121.183 -0.948 . . . . 0.88 109.655 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -100.35 127.65 46.61 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.006 -1.059 . . . . 0.52 111.394 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 25' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.5 2.044 0 O-C-N 121.628 -0.67 . . . . 1.16 110.088 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.853 0 N-CA-C 110.768 -0.933 . . . . 0.67 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -83.29 -63.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.192 -1.181 . . . . 0.61 110.442 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -173.17 151.21 2.04 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.363 -0.836 . . . . 0.4 110.393 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 51.1 t -167.16 158.16 11.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.237 -0.915 . . . . 0.35 110.552 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.623 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.3 OUTLIER -109.04 179.88 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.582 -0.698 . . . . 0.45 109.566 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 21' ' ' ALA . 1.3 mp -85.13 -69.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.971 -1.08 . . . . 0.51 108.779 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.2 p90 -60.22 -38.23 82.75 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.827 0.822 . . . . 0.39 109.133 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.623 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -94.04 102.42 14.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.559 0.695 . . . . 0.34 109.96 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -88.02 131.16 34.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.196 -0.94 . . . . 0.44 109.678 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -118.84 23.56 11.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.786 -1.197 . . . . 0.7 112.037 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -95.33 101.95 13.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.913 -1.117 . . . . 0.61 109.267 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.94 -37.36 8.88 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.549 -0.719 . . . . 1.26 111.533 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.34 52.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 119.614 -0.835 . . . . 1.08 110.364 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -166.31 164.66 37.74 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.736 -1.221 . . . . 0.55 110.972 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.56 157.99 33.12 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.448 -1.031 . . . . 1.11 109.708 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -139.61 19.02 2.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.707 -1.245 . . . . 0.35 113.527 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -22.83 -59.8 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 CA-C-N 119.367 0.985 . . . . 0.44 111.743 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' C ' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -140.61 14.95 2.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.661 -0.649 . . . . 1.0 110.124 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.57 140.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.319 -0.863 . . . . 0.66 109.399 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.1 t -94.32 110.42 22.18 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.716 -1.24 . . . . 0.47 110.547 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.457 HD11 HD12 ' A' ' 23' ' ' ILE . 13.6 mt . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.572 . . . . 1.29 109.472 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.725 0 N-CA-C 111.676 -0.569 . . . . 1.14 111.676 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -74.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.064 1.432 . . . . 1.09 110.736 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -176.12 155.52 1.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.02 -1.05 . . . . 0.69 110.234 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 39.6 t 179.73 153.22 0.47 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.974 . . . . 0.62 111.617 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.65 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -112.53 -178.37 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.727 -0.842 . . . . 0.77 108.727 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.83 -68.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.781 -1.199 . . . . 1.31 108.723 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.8 p90 -62.09 -36.79 82.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.676 0.75 . . . . 1.25 109.686 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -96.03 96.67 9.03 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.653 0.74 . . . . 0.85 110.141 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -86.31 135.07 33.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.103 -0.998 . . . . 0.83 109.71 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.5 m-80 -101.67 -11.96 18.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.87 -1.144 . . . . 0.77 110.861 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 55.0 m -85.6 103.73 14.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.26 -0.9 . . . . 0.85 109.906 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.2 m -50.16 -36.84 31.86 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.378 -0.826 . . . . 1.27 110.36 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.88 51.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 120.071 -0.652 . . . . 1.55 110.614 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.32 142.56 9.03 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.547 -1.311 . . . . 0.89 110.783 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.12 129.87 43.51 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -1.043 . . . . 0.82 109.402 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.36 14.49 12.05 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.521 -0.872 . . . . 0.54 113.285 -178.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.02 -63.32 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 118.633 0.651 . . . . 0.89 112.497 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.425 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.49 12.85 3.23 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.806 . . . . 1.74 110.794 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.87 156.59 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 0.81 109.251 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -106.97 127.85 53.82 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.01 -1.056 . . . . 0.57 111.476 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 121.556 0.693 . . . . 0.78 109.864 179.35 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.853 -1.299 . . . . 0.54 109.853 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 157.32 12.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -1.131 . . . . 0.49 111.059 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -52.07 156.21 1.65 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.556 0.693 . . . . 0.9 111.95 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 42.7 t -170.19 148.35 3.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.491 -0.756 . . . . 0.48 110.829 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.659 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.8 m-20 -104.33 175.96 5.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.827 . . . . 0.63 109.865 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.4 mp -78.12 -71.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.069 -1.02 . . . . 0.9 108.973 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -58.36 -36.92 74.2 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.702 0.763 . . . . 0.93 109.602 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.659 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.2 t -97.21 97.21 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.758 0.79 . . . . 0.65 109.765 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.32 145.15 32.26 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.158 -0.964 . . . . 0.62 110.359 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 1.9 m-80 -103.17 -16.41 15.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.965 -1.085 . . . . 0.44 110.552 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 2.3 m -81.13 107.69 14.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.139 -0.976 . . . . 0.42 109.653 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -49.5 -37.83 28.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.249 -0.907 . . . . 0.74 109.991 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.82 52.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 120.184 -0.607 . . . . 0.91 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -159.01 155.43 26.5 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.424 -1.369 . . . . 0.46 110.951 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 t -71.76 148.51 46.25 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.417 -1.049 . . . . 0.5 109.903 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -142.73 24.61 1.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.082 -1.011 . . . . 0.38 112.537 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.39 -58.15 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 118.706 0.685 . . . . 0.61 111.993 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.2 15.1 2.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.47 -0.769 . . . . 1.58 110.691 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.77 147.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 O-C-N 121.374 -0.829 . . . . 0.62 109.276 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.0 t -100.74 138.33 37.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.076 -1.015 . . . . 0.34 112.318 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.645 0.736 . . . . 0.7 109.368 178.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 N-CA-C 110.818 -0.913 . . . . 1.74 110.818 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.78 -63.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.984 -1.304 . . . . 1.85 110.687 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 79.7 p -164.21 165.26 22.18 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.249 -0.907 . . . . 1.26 110.429 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 25.8 t -178.62 145.8 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.146 -0.971 . . . . 0.68 111.826 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.666 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.2 m-20 -110.77 174.86 5.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.76 108.599 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.2 mp -81.22 -70.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.924 -1.11 . . . . 1.55 108.771 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 12' ' ' SER . 32.1 p90 -58.92 -36.0 74.01 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.696 0.76 . . . . 1.48 109.404 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.666 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.3 t -97.67 95.93 7.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.577 0.703 . . . . 1.01 110.072 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -74.53 132.98 42.3 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.12 -0.988 . . . . 1.36 109.775 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.4 m-80 -96.14 -37.4 10.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.128 . . . . 0.98 111.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 m -53.75 113.51 1.22 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.17 -0.956 . . . . 1.2 110.025 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.0 m -45.69 -40.67 9.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.371 -0.831 . . . . 1.81 110.741 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -144.27 47.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.31 0.576 . . . . 2.01 109.853 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.75 157.91 27.51 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.566 -1.302 . . . . 1.22 110.806 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -64.21 150.32 46.09 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.956 . . . . 1.79 109.667 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -147.3 25.26 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.156 -1.018 . . . . 1.19 112.859 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.71 -59.86 0.09 Allowed 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 118.973 0.806 . . . . 1.85 111.376 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.43 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -138.66 17.04 2.7 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.626 -0.671 . . . . 2.25 110.346 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -171.55 144.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 O-C-N 121.193 -0.942 . . . . 1.87 109.979 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.5 t -99.35 112.52 24.68 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.945 -1.097 . . . . 0.7 110.482 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 25' ' ' ILE . 1.6 tt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.919 0.866 . . . . 1.49 110.346 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 111.03 -0.828 . . . . 0.75 111.03 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -76.79 -69.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.942 -1.328 . . . . 1.05 110.085 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.4 148.04 4.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.205 -0.935 . . . . 0.85 110.42 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -173.74 148.09 1.44 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.752 . . . . 0.73 110.119 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -109.85 -176.25 2.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 1.38 109.576 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.4 mp -79.82 -65.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 1.11 108.711 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.5 p90 -65.36 -37.14 86.13 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.707 0.765 . . . . 1.15 109.198 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.667 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.7 t -94.29 95.54 8.98 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.715 0.769 . . . . 1.01 109.742 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.7 129.41 36.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.298 -0.876 . . . . 0.59 109.847 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.89 19.06 13.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.15 -0.969 . . . . 0.94 111.724 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -93.13 90.47 6.89 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.174 -0.954 . . . . 0.58 109.678 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.7 m -53.45 -32.97 52.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.449 -0.782 . . . . 0.95 111.43 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.1 48.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.288 -0.883 . . . . 1.46 111.307 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . 179.36 171.97 43.02 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.55 -1.31 . . . . 0.58 111.066 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -80.65 165.45 22.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.415 -1.05 . . . . 0.67 109.669 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -142.3 19.17 2.07 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.689 -1.257 . . . . 0.32 113.376 -178.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.13 -60.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.256 0.934 . . . . 0.55 111.63 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.78 13.22 2.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 1.29 110.466 178.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.39 149.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 O-C-N 121.416 -0.803 . . . . 0.75 109.398 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 11.1 t -99.02 112.93 24.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.992 -1.068 . . . . 0.55 110.631 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 23' ' ' ILE . 33.3 mt . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.551 -0.718 . . . . 1.37 109.409 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.877 0 N-CA-C 111.029 -0.828 . . . . 0.83 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.19 -66.64 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.957 -1.319 . . . . 0.97 110.941 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -171.9 146.1 1.98 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.169 -0.957 . . . . 0.5 110.733 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.636 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 41.2 t -170.68 154.42 4.45 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.271 -0.893 . . . . 0.5 110.956 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.611 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 3.3 m-20 -104.52 -173.51 2.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.705 -0.622 . . . . 0.69 109.898 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.1 mp -88.53 -66.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.211 -0.93 . . . . 0.89 108.56 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -64.83 -36.85 85.65 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.863 0.84 . . . . 0.94 109.005 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.611 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.2 t -94.05 93.65 7.97 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.716 0.77 . . . . 0.68 109.574 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -86.53 133.66 33.72 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.099 -1.001 . . . . 0.54 109.885 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -117.78 12.21 13.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.892 -1.13 . . . . 0.74 111.901 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.71 106.48 8.4 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.936 -1.102 . . . . 0.73 109.323 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.4 m -44.36 -31.5 1.06 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.586 -0.696 . . . . 0.82 111.302 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.0 p -156.25 49.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.807 0.813 . . . . 0.61 109.957 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.23 168.67 34.14 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.568 -1.301 . . . . 0.6 111.15 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.42 150.57 33.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.574 -0.957 . . . . 1.59 110.043 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -132.91 15.97 4.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.911 -1.118 . . . . 0.56 112.973 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.08 -63.53 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 118.902 0.774 . . . . 0.79 111.974 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.04 11.3 3.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 1.69 110.291 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -169.18 143.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.463 -0.773 . . . . 1.03 108.961 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 49.3 t -95.71 114.02 25.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.798 -1.189 . . . . 0.63 110.705 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 25' ' ' ILE . 1.4 tp . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.402 0.62 . . . . 1.26 110.137 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 109.643 -1.383 . . . . 0.33 109.643 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.16 151.18 9.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.505 -0.997 . . . . 0.79 111.098 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.28 157.36 0.48 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.464 0.649 . . . . 0.67 111.558 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.409 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 41.0 t -170.52 149.31 3.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.251 -0.905 . . . . 0.33 110.914 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.646 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.4 m-20 -102.3 -179.23 3.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 0.52 109.586 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.08 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.057 -1.027 . . . . 0.6 108.793 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.6 p90 -57.19 -38.14 73.23 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.739 0.78 . . . . 0.54 109.307 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.0 t -94.37 98.66 11.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.714 0.768 . . . . 0.43 109.647 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.62 140.69 33.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.317 -0.864 . . . . 0.51 110.357 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.0 m-80 -96.65 -19.75 18.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.066 -1.021 . . . . 0.38 110.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.9 m -79.23 111.47 15.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.129 -0.982 . . . . 0.26 109.698 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.31 -35.61 8.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.358 -0.839 . . . . 0.42 109.928 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 17' ' ' VAL . 14.5 p -142.71 52.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.535 0.683 . . . . 0.52 110.2 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.3 151.42 23.47 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.461 -1.352 . . . . 0.28 110.964 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.28 124.85 24.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.476 -1.014 . . . . 0.77 109.589 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -123.76 23.34 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.207 -0.933 . . . . 0.27 112.472 -178.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.51 -56.96 0.08 Allowed 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.628 -0.67 . . . . 0.4 112.084 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -139.23 15.74 2.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.437 -0.79 . . . . 1.4 110.405 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.29 145.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.493 -0.754 . . . . 0.66 109.345 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 29.1 t -99.15 136.46 39.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.27 111.726 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 25' ' ' ILE . 3.8 mt . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.536 0.684 . . . . 0.88 109.553 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.723 0 N-CA-C 110.571 -1.012 . . . . 0.34 110.571 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -170.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.278 . . . . 0.58 110.681 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 146.99 52.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.169 -0.957 . . . . 1.08 111.535 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.669 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 19.4 t -171.71 156.46 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.552 -0.717 . . . . 0.38 110.848 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 4.0 m-20 -113.64 -175.33 2.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.68 -0.637 . . . . 0.52 109.915 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.0 mp -78.32 -66.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.296 -0.877 . . . . 0.56 108.929 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -69.05 -38.14 78.93 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.745 0.783 . . . . 0.52 109.387 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 5.1 t -94.94 95.85 8.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.807 -0.812 . . . . 0.5 108.807 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.669 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -96.01 150.19 20.74 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.215 -0.928 . . . . 0.45 112.014 -177.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.64 -1.33 15.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.443 -0.785 . . . . 0.49 110.572 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 m -88.17 96.04 10.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.954 -1.091 . . . . 0.33 109.783 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -55.11 -26.15 36.31 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.201 -0.937 . . . . 0.69 110.933 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.45 46.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.203 -0.935 . . . . 0.75 110.802 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -171.55 165.0 37.89 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.411 -1.076 . . . . 0.77 110.411 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -84.26 167.9 16.19 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.335 -1.097 . . . . 0.79 110.382 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -143.17 24.81 1.78 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.271 -0.893 . . . . 0.69 112.523 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -17.88 -66.75 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 118.582 0.628 . . . . 0.73 111.95 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -131.14 6.47 4.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.539 -0.726 . . . . 1.66 110.815 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.13 152.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.741 -0.837 . . . . 0.71 108.741 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.623 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 30.1 t -86.15 118.04 25.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.45 111.233 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 25' ' ' ILE . 1.3 tp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.316 0.579 . . . . 1.38 110.009 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 2.0 m . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.273 -0.64 . . . . 1.67 109.273 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -152.38 154.74 36.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 1.31 110.858 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -77.22 153.43 34.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.405 -0.81 . . . . 3.59 110.543 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 25' ' ' ILE . . . -58.68 124.0 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 1.4 109.747 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.82 -27.8 9.43 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.091 -1.603 . . . . 1.13 109.091 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.89 155.73 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -1.054 . . . . 1.8 110.79 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.27 158.68 2.98 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.641 0.734 . . . . 1.23 111.819 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 36.5 t -174.26 152.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.56 110.923 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.9 m-20 -107.6 178.03 4.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.575 -0.703 . . . . 1.26 109.496 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 10' ' ' ILE . 2.1 mp -77.69 -67.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 120.979 -1.076 . . . . 1.38 108.906 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.6 p90 -63.87 -37.59 87.95 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.647 0.736 . . . . 1.75 109.535 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.635 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.1 t -96.51 95.51 8.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.856 0.836 . . . . 1.34 109.718 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -86.55 140.47 29.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.156 -0.965 . . . . 0.95 110.447 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -98.25 -14.5 20.26 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.069 . . . . 1.06 110.082 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 26' ' ' GLU . 64.8 m -89.57 108.18 19.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.49 -0.756 . . . . 0.57 109.882 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -51.84 -42.89 62.94 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 1.1 110.421 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.59 48.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.063 -0.655 . . . . 0.6 110.009 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.64 131.03 3.72 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.828 -1.177 . . . . 0.71 110.276 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.87 124.89 18.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.521 -0.988 . . . . 1.69 109.761 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.91 17.21 11.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.69 112.958 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.4 -59.38 0.07 Allowed 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 118.725 0.693 . . . . 1.17 111.941 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 2.7 m-85 -136.65 13.78 3.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.526 -0.734 . . . . 1.76 110.602 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.36 146.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 121.301 -0.874 . . . . 1.09 109.726 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.709 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -95.92 127.35 41.86 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.255 -0.903 . . . . 0.75 111.396 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 3.1 mt -123.95 55.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 1.17 110.321 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.183 ' HG2' ' N ' ' A' ' 27' ' ' NH2 . 17.9 tt0 -122.3 -126.91 0.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.003 -1.061 . . . . 1.2 110.286 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . 1.183 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.38 1.893 0 O-C-N 119.325 -2.109 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 120.98 0.419 . . . . 0.49 110.128 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -142.35 -160.94 1.16 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.481 -0.762 . . . . 0.71 110.816 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.4 mt-30 -79.19 154.13 29.49 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.347 -0.845 . . . . 0.96 111.777 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.35 142.57 54.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.485 -0.76 . . . . 0.51 111.042 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.43 -13.54 66.24 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 120.486 -0.864 . . . . 0.44 111.023 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 3.3 mt-10 -73.61 -178.79 3.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.291 . . . . 0.48 110.781 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -66.01 151.13 47.5 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.268 -0.895 . . . . 0.8 110.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 21.9 t -170.44 155.32 5.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.155 -0.966 . . . . 0.38 110.925 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -111.39 -171.33 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.62 -0.675 . . . . 0.64 109.859 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.5 mp -83.84 -70.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.228 -0.92 . . . . 0.69 108.649 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.4 p90 -60.86 -36.74 79.95 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.839 0.828 . . . . 0.68 109.363 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.1 t -96.81 104.1 16.07 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.306 -0.627 . . . . 0.55 109.306 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.536 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 1.5 mm-40 -98.86 144.59 27.89 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.035 -1.041 . . . . 0.41 111.154 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 2.9 t-20 -108.61 -4.58 17.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.086 -1.009 . . . . 0.56 110.72 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.554 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 22.0 m -90.07 103.66 16.31 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.118 -0.989 . . . . 0.33 109.515 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.5 m -50.17 -31.38 13.51 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.51 -0.744 . . . . 0.49 110.721 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.42 48.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.527 -0.733 . . . . 0.72 110.714 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.65 147.27 16.19 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.8 -1.19 . . . . 0.43 110.699 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.0 48.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -1.024 . . . . 1.05 109.855 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -118.42 9.95 12.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.153 -0.967 . . . . 0.43 112.156 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -19.19 -63.29 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 118.516 0.598 . . . . 0.66 112.284 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.436 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.36 3.93 4.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.569 -0.707 . . . . 1.41 110.71 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.996 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -165.11 144.43 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.311 -0.868 . . . . 0.56 108.991 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.703 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 4.2 t -77.42 88.61 3.79 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.085 -1.01 . . . . 0.45 110.956 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.996 HD11 HD12 ' A' ' 23' ' ' ILE . 8.4 mt -106.35 114.99 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 1.37 109.824 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -114.89 169.17 9.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.302 -0.874 . . . . 1.25 110.755 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.927 0 O-C-N 119.348 -2.095 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 120.755 0.312 . . . . 1.14 110.204 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -130.44 174.22 10.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.421 -0.8 . . . . 0.67 110.151 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.68 151.34 30.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.198 -0.939 . . . . 1.43 110.693 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . . . -58.78 126.98 29.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 0.95 110.012 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.27 7.53 72.49 Favored Glycine 0 N--CA 1.498 2.802 0 C-N-CA 120.291 -0.957 . . . . 0.91 110.846 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -85.91 -62.73 1.46 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.0 -1.294 . . . . 0.93 110.232 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -173.15 144.61 1.24 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.345 -0.847 . . . . 1.1 110.65 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 35.6 t -172.8 155.15 3.12 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.376 -0.827 . . . . 0.53 110.256 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -110.63 -178.59 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.714 . . . . 0.88 110.223 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.5 mp -79.42 -64.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.254 -0.904 . . . . 0.89 108.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.7 p90 -67.72 -37.82 82.73 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.782 0.801 . . . . 0.93 109.213 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.6 t -94.32 89.16 5.8 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.722 0.772 . . . . 0.73 109.688 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -84.98 139.01 32.11 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.282 -0.886 . . . . 0.59 109.916 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 4.5 m-80 -126.99 15.29 7.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.966 -1.083 . . . . 0.88 112.187 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 m -78.23 104.96 9.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.858 -1.151 . . . . 0.9 108.784 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m -46.59 -38.35 9.42 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.459 -0.776 . . . . 1.35 111.271 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.631 HG23 ' HG3' ' A' ' 26' ' ' GLU . 5.8 m -141.57 50.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.769 -0.582 . . . . 1.66 110.246 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.72 168.32 38.93 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 119.582 -1.294 . . . . 1.08 111.142 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -80.93 160.67 24.61 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.497 -1.002 . . . . 0.84 110.214 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -138.49 20.07 2.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.025 -1.047 . . . . 0.35 112.756 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.42 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 118.967 0.803 . . . . 0.57 111.774 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.1 10.76 3.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.54 -0.725 . . . . 1.77 110.57 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -170.86 147.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 O-C-N 121.3 -0.875 . . . . 1.49 109.214 -179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 51.6 t -95.2 107.03 19.1 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.831 -1.168 . . . . 0.76 110.76 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.569 HD11 HD12 ' A' ' 23' ' ' ILE . 19.3 mt -118.99 100.92 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.722 -0.611 . . . . 1.55 109.532 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -79.24 147.42 32.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.42 -0.8 . . . . 2.3 110.639 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.914 0 O-C-N 119.275 -2.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 109.986 -0.375 . . . . 0.49 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.82 ' HE2' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -174.95 -173.8 0.72 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.416 -0.802 . . . . 0.49 111.128 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.557 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -85.88 169.65 13.1 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.115 -0.99 . . . . 0.88 110.729 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.98 135.01 51.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.806 -1.184 . . . . 0.49 109.499 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.63 52.03 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.384 -1.087 . . . . 0.39 110.384 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.26 169.6 3.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -1.158 . . . . 0.58 111.053 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.08 160.51 26.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.214 -0.929 . . . . 0.42 111.247 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.555 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 1.7 t 176.85 156.25 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.449 -0.782 . . . . 0.35 110.082 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.4 m-20 -111.23 -176.56 2.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.854 . . . . 0.7 110.156 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.5 mp -78.35 -67.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.271 -0.893 . . . . 0.54 108.654 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.0 p90 -64.17 -35.99 82.6 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.723 0.773 . . . . 0.58 109.371 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.5 t -98.67 95.62 7.38 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.588 0.709 . . . . 0.57 109.204 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.555 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -92.98 144.21 25.48 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.121 -0.987 . . . . 0.43 111.208 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -109.17 1.7 20.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.224 -0.922 . . . . 0.52 110.49 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.046 -1.034 . . . . 0.75 108.764 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.0 m -53.55 -28.42 31.52 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.043 -1.035 . . . . 0.58 111.85 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 47.11 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 1.0 110.665 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -161.97 153.0 23.57 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.155 -1.178 . . . . 0.49 110.155 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.65 147.07 41.88 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -1.079 . . . . 0.84 110.176 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -129.77 24.41 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.014 -1.054 . . . . 0.47 112.291 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.37 -58.1 0.05 Allowed 'General case' 0 N--CA 1.513 2.714 0 CA-C-N 118.624 0.647 . . . . 0.52 111.312 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.77 11.23 2.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 1.03 110.761 178.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -169.25 148.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 121.263 -0.898 . . . . 0.51 109.628 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.82 ' SG ' ' HE2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -88.44 100.23 12.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.115 -0.99 . . . . 0.44 111.321 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.728 HD11 HD12 ' A' ' 23' ' ' ILE . 25.0 mt -117.5 118.94 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.631 -0.668 . . . . 1.12 109.715 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.467 ' OE1' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -106.33 136.82 45.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.365 -0.834 . . . . 1.12 110.316 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 1.944 0 O-C-N 119.438 -2.039 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 75.6 m . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.009 0.433 . . . . 2.14 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 13.0 mttt -125.12 161.77 26.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 1.85 110.422 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.3 mm100 -69.95 167.57 17.18 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.401 -0.812 . . . . 1.99 111.411 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -65.73 116.76 7.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.292 -0.88 . . . . 1.04 110.181 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.24 -3.72 69.79 Favored Glycine 0 N--CA 1.499 2.851 0 C-N-CA 120.18 -1.01 . . . . 1.66 110.742 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -66.98 -68.86 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.078 -1.248 . . . . 2.08 110.266 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m 176.16 149.91 0.13 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.548 -0.72 . . . . 1.91 109.845 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -176.89 156.67 1.37 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.324 -0.86 . . . . 1.06 110.273 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.1 m-20 -110.52 179.96 3.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.442 -0.786 . . . . 1.37 110.152 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.7 mp -79.9 -68.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.03 -1.043 . . . . 1.63 108.871 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.1 p90 -61.41 -36.22 79.71 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.763 0.792 . . . . 1.32 109.289 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -99.27 95.39 7.04 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.623 0.725 . . . . 0.84 109.52 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -89.16 137.49 32.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.033 -1.042 . . . . 0.97 109.982 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -116.37 33.64 5.44 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.996 -1.065 . . . . 1.46 111.37 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.24 100.53 10.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.884 -1.135 . . . . 1.27 109.815 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -36.37 8.34 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.643 -0.661 . . . . 2.25 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.5 53.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.065 -0.654 . . . . 2.22 110.884 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.96 165.47 38.81 Favored Glycine 0 N--CA 1.505 3.249 0 C-N-CA 119.751 -1.214 . . . . 1.4 111.228 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.6 p -82.32 168.91 17.08 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.376 -1.073 . . . . 1.93 110.137 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -150.45 27.06 0.75 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.732 -1.23 . . . . 0.9 113.481 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.36 -58.33 0.06 Allowed 'General case' 0 N--CA 1.517 2.914 0 CA-C-N 119.214 0.916 . . . . 1.62 111.948 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -140.28 17.22 2.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.397 -0.814 . . . . 2.6 110.731 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.0 149.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 O-C-N 121.488 -0.758 . . . . 1.55 109.726 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -103.9 134.18 47.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.085 -1.009 . . . . 0.82 110.654 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 25' ' ' ILE . 3.3 mt -124.04 61.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.562 -0.711 . . . . 1.17 110.005 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.08 139.92 48.68 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.086 -1.009 . . . . 1.43 110.451 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.934 0 O-C-N 119.343 -2.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 1.2 m . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.144 0.497 . . . . 0.56 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -145.16 136.79 25.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.687 -0.633 . . . . 0.65 110.247 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 171.76 3.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 2.12 110.521 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -63.18 110.21 1.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.175 -0.953 . . . . 0.4 110.553 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.93 -2.7 61.95 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.768 -0.933 . . . . 0.47 110.768 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' OE2' ' HG3' ' A' ' 2' ' ' LYS . 8.4 tt0 -72.1 -62.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.279 . . . . 0.59 109.792 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.9 OUTLIER 178.39 157.22 0.45 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.654 -0.654 . . . . 0.98 109.916 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.0 t -179.28 143.61 0.21 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.228 -0.92 . . . . 0.44 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.701 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 5.2 m-20 -105.3 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.149 -0.686 . . . . 0.75 109.149 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.2 mp -79.45 -64.67 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.889 -1.132 . . . . 0.54 108.477 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -65.15 -36.61 84.79 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.723 0.773 . . . . 0.45 109.355 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.701 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.9 t -96.46 95.28 7.91 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.882 0.849 . . . . 0.57 110.054 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -90.45 134.14 34.55 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.184 -0.947 . . . . 0.54 109.345 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 2.2 m-80 -113.64 23.16 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.767 -1.208 . . . . 0.59 112.062 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 73.7 m -87.87 97.85 11.15 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.726 -1.234 . . . . 0.37 109.556 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -45.5 -38.5 6.32 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.478 -0.764 . . . . 0.77 110.483 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.87 51.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 120.316 -0.553 . . . . 0.63 110.819 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -166.56 174.77 42.01 Favored Glycine 0 N--CA 1.502 3.074 0 C-N-CA 119.91 -1.138 . . . . 0.36 110.735 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 p -88.22 155.88 19.52 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.353 -1.086 . . . . 0.6 109.956 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.618 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -140.56 28.36 2.01 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.889 -1.132 . . . . 0.28 112.513 -178.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -23.6 -60.18 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 O-C-N 121.686 -0.633 . . . . 0.43 111.827 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.82 16.56 2.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.563 -0.711 . . . . 1.17 110.18 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.78 152.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 O-C-N 121.534 -0.729 . . . . 0.86 109.472 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 8.0 t -105.6 139.51 40.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.753 -1.217 . . . . 0.26 110.983 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.449 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.9 mt -133.08 64.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.635 0.731 . . . . 0.8 109.521 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.93 109.76 7.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.185 -0.947 . . . . 1.45 110.845 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.864 0 O-C-N 119.293 -2.13 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.109 0.48 . . . . 0.91 109.85 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -130.11 135.63 48.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.551 -0.718 . . . . 0.95 109.757 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -53.43 155.33 2.95 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.512 -0.742 . . . . 2.05 111.558 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 25' ' ' ILE . . . -52.48 129.82 29.9 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.321 -0.862 . . . . 0.9 110.88 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.23 -26.14 19.68 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.92 -1.272 . . . . 0.74 109.92 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 2.5 mm-40 -65.06 169.7 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -1.077 . . . . 1.57 110.685 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.508 ' OG ' ' NZ ' ' A' ' 2' ' ' LYS . 1.6 p -59.14 158.0 9.5 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.398 -0.814 . . . . 0.64 111.623 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -178.44 138.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.58 109.921 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -105.73 179.01 4.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.536 -0.728 . . . . 0.81 109.53 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.55 HD12 ' H ' ' A' ' 10' ' ' ILE . 1.6 mp -74.06 -65.67 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.188 -0.945 . . . . 1.21 108.721 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.55 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.9 p90 -67.46 -38.39 84.38 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.743 0.782 . . . . 1.32 109.253 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.671 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -95.05 91.1 6.18 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.771 0.796 . . . . 1.04 109.2 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -87.28 132.49 33.9 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.058 -1.026 . . . . 0.88 109.976 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' OD1' ' HE3' ' A' ' 2' ' ' LYS . 2.2 m-80 -96.19 2.82 53.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.839 -1.163 . . . . 1.12 110.73 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 38.8 m -101.83 103.24 13.93 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.238 -0.914 . . . . 0.46 109.849 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 96.4 m -52.24 -33.56 42.06 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.47 -0.769 . . . . 0.81 110.932 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 17' ' ' VAL . 7.8 p -137.93 45.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.766 0.793 . . . . 0.57 110.217 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.1 137.94 6.78 Favored Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.094 -1.202 . . . . 0.47 110.094 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.95 133.31 51.5 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.54 -0.976 . . . . 1.33 109.601 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -125.74 11.54 7.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.925 -1.109 . . . . 0.64 112.941 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -21.25 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 118.701 0.682 . . . . 1.04 112.304 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -135.09 10.2 3.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.405 -0.809 . . . . 1.77 110.832 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.01 156.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 121.183 -0.948 . . . . 0.88 109.655 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -100.35 127.65 46.61 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.006 -1.059 . . . . 0.52 111.394 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.427 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.6 mp -124.5 57.04 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.628 -0.67 . . . . 1.16 110.088 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 2.7 tt0 -87.35 111.31 20.95 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.985 -1.072 . . . . 1.51 110.722 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.929 0 O-C-N 119.282 -2.136 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 110.18 -0.304 . . . . 1.0 110.18 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 3.4 mtpp -136.2 -173.31 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.444 -0.785 . . . . 0.73 110.583 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 4.3 mt-30 -80.28 150.5 29.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.242 -0.911 . . . . 0.96 111.37 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . . . -62.33 126.5 27.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.323 -0.861 . . . . 0.73 110.352 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.46 3.13 82.17 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.768 -0.933 . . . . 0.67 110.768 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 3' ' ' GLN . 2.3 tt0 -83.29 -63.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.192 -1.181 . . . . 0.61 110.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 1.6 m -173.17 151.21 2.04 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.363 -0.836 . . . . 0.4 110.393 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 51.1 t -167.16 158.16 11.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.237 -0.915 . . . . 0.35 110.552 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.623 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.3 OUTLIER -109.04 179.88 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.582 -0.698 . . . . 0.45 109.566 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 21' ' ' ALA . 1.3 mp -85.13 -69.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.971 -1.08 . . . . 0.51 108.779 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.2 p90 -60.22 -38.23 82.75 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.827 0.822 . . . . 0.39 109.133 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.623 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.4 t -94.04 102.42 14.49 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.559 0.695 . . . . 0.34 109.96 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -88.02 131.16 34.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.196 -0.94 . . . . 0.44 109.678 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 4.3 m-80 -118.84 23.56 11.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.786 -1.197 . . . . 0.7 112.037 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -95.33 101.95 13.71 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.913 -1.117 . . . . 0.61 109.267 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.7 m -46.94 -37.36 8.88 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.549 -0.719 . . . . 1.26 111.533 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.502 HG23 ' HG3' ' A' ' 26' ' ' GLU . 16.4 m -141.34 52.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 119.614 -0.835 . . . . 1.08 110.364 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . -166.31 164.66 37.74 Favored Glycine 0 N--CA 1.501 3.004 0 C-N-CA 119.736 -1.221 . . . . 0.55 110.972 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.56 157.99 33.12 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.448 -1.031 . . . . 1.11 109.708 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -139.61 19.02 2.53 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.707 -1.245 . . . . 0.35 113.527 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -22.83 -59.8 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 CA-C-N 119.367 0.985 . . . . 0.44 111.743 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' C ' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -140.61 14.95 2.34 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.661 -0.649 . . . . 1.0 110.124 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -170.57 140.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.319 -0.863 . . . . 0.66 109.399 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.68 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.1 t -94.32 110.42 22.18 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.716 -1.24 . . . . 0.47 110.547 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.457 HD11 HD12 ' A' ' 23' ' ' ILE . 13.6 mt -122.3 135.52 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.572 . . . . 1.29 109.472 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -103.35 160.34 14.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 3.5 110.475 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.926 0 O-C-N 119.423 -2.048 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.912 -0.403 . . . . 1.49 109.912 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.495 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 13.9 mttt -156.27 124.68 5.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.754 -0.591 . . . . 0.9 109.875 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 -57.96 155.88 10.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.443 -0.786 . . . . 1.49 110.806 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -54.88 123.0 12.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.377 -0.827 . . . . 1.13 110.95 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.67 61.65 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 120.376 -0.916 . . . . 1.14 111.676 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -67.16 -74.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.064 1.432 . . . . 1.09 110.736 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -176.12 155.52 1.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.02 -1.05 . . . . 0.69 110.234 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 39.6 t 179.73 153.22 0.47 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.974 . . . . 0.62 111.617 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.65 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -112.53 -178.37 3.39 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.727 -0.842 . . . . 0.77 108.727 178.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.83 -68.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.781 -1.199 . . . . 1.31 108.723 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.8 p90 -62.09 -36.79 82.75 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.676 0.75 . . . . 1.25 109.686 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.65 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.0 t -96.03 96.67 9.03 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.653 0.74 . . . . 0.85 110.141 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -86.31 135.07 33.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.103 -0.998 . . . . 0.83 109.71 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.5 m-80 -101.67 -11.96 18.77 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.87 -1.144 . . . . 0.77 110.861 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 55.0 m -85.6 103.73 14.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.26 -0.9 . . . . 0.85 109.906 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.2 m -50.16 -36.84 31.86 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.378 -0.826 . . . . 1.27 110.36 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.88 51.06 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 120.071 -0.652 . . . . 1.55 110.614 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.32 142.56 9.03 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.547 -1.311 . . . . 0.89 110.783 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.12 129.87 43.51 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -1.043 . . . . 0.82 109.402 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -120.36 14.49 12.05 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.521 -0.872 . . . . 0.54 113.285 -178.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.02 -63.32 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 118.633 0.651 . . . . 0.89 112.497 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.425 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.49 12.85 3.23 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.806 . . . . 1.74 110.794 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.87 156.59 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.201 -0.937 . . . . 0.81 109.251 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -106.97 127.85 53.82 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.01 -1.056 . . . . 0.57 111.476 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.55 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.6 mt -123.2 54.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.556 0.693 . . . . 0.78 109.864 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.997 ' HG2' ' N ' ' A' ' 27' ' ' NH2 . 17.8 tt0 -108.88 -146.08 0.4 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.116 -0.99 . . . . 1.18 110.631 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . 0.997 ' N ' ' HG2' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.38 1.904 0 O-C-N 119.194 -2.191 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 2' ' ' LYS . 35.0 m . . . . . 0 N--CA 1.501 2.093 0 N-CA-C 109.724 -0.473 . . . . 1.21 109.724 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -154.49 121.49 5.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.702 . . . . 0.44 110.481 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -55.61 148.2 16.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.547 -0.72 . . . . 1.48 110.91 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 25' ' ' ILE . . . -49.94 128.85 19.47 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.407 -0.808 . . . . 0.59 110.598 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.19 -32.74 6.77 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.853 -1.299 . . . . 0.54 109.853 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -59.87 157.32 12.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -1.131 . . . . 0.49 111.059 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -52.07 156.21 1.65 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.556 0.693 . . . . 0.9 111.95 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 42.7 t -170.19 148.35 3.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.491 -0.756 . . . . 0.48 110.829 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.659 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.8 m-20 -104.33 175.96 5.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.827 . . . . 0.63 109.865 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.4 mp -78.12 -71.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.069 -1.02 . . . . 0.9 108.973 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -58.36 -36.92 74.2 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.702 0.763 . . . . 0.93 109.602 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.659 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 3.2 t -97.21 97.21 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.758 0.79 . . . . 0.65 109.765 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.32 145.15 32.26 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.158 -0.964 . . . . 0.62 110.359 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 1.9 m-80 -103.17 -16.41 15.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.965 -1.085 . . . . 0.44 110.552 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . 2.3 m -81.13 107.69 14.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.139 -0.976 . . . . 0.42 109.653 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -49.5 -37.83 28.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.249 -0.907 . . . . 0.74 109.991 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.82 52.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 120.184 -0.607 . . . . 0.91 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -159.01 155.43 26.5 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.424 -1.369 . . . . 0.46 110.951 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 t -71.76 148.51 46.25 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.417 -1.049 . . . . 0.5 109.903 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -142.73 24.61 1.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.082 -1.011 . . . . 0.38 112.537 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -25.39 -58.15 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 118.706 0.685 . . . . 0.61 111.993 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -139.2 15.1 2.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.47 -0.769 . . . . 1.58 110.691 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.77 147.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 O-C-N 121.374 -0.829 . . . . 0.62 109.276 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.0 t -100.74 138.33 37.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.076 -1.015 . . . . 0.34 112.318 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.556 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 2.4 mp -128.75 54.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.645 0.736 . . . . 0.7 109.368 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 19.8 tt0 -99.15 175.81 5.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.235 -0.916 . . . . 0.62 110.786 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . 0.475 ' N ' ' CG ' ' A' ' 26' ' ' GLU . . . . . . . . 0 C--N 1.381 1.943 0 O-C-N 119.169 -2.207 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 120.941 0.401 . . . . 1.95 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -151.31 175.91 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.717 -0.614 . . . . 1.54 110.159 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -78.68 144.51 35.27 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 1.61 111.197 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.56 126.99 29.5 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.316 -0.865 . . . . 1.31 110.078 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.92 -2.82 67.26 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.818 -0.913 . . . . 1.74 110.818 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.78 -63.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.984 -1.304 . . . . 1.85 110.687 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 79.7 p -164.21 165.26 22.18 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.249 -0.907 . . . . 1.26 110.429 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 25.8 t -178.62 145.8 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.146 -0.971 . . . . 0.68 111.826 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.666 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.2 m-20 -110.77 174.86 5.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.76 108.599 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.2 mp -81.22 -70.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.924 -1.11 . . . . 1.55 108.771 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 12' ' ' SER . 32.1 p90 -58.92 -36.0 74.01 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.696 0.76 . . . . 1.48 109.404 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.666 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.3 t -97.67 95.93 7.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.577 0.703 . . . . 1.01 110.072 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -74.53 132.98 42.3 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.12 -0.988 . . . . 1.36 109.775 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . 2.4 m-80 -96.14 -37.4 10.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.128 . . . . 0.98 111.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.5 m -53.75 113.51 1.22 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.17 -0.956 . . . . 1.2 110.025 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.0 m -45.69 -40.67 9.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.371 -0.831 . . . . 1.81 110.741 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -144.27 47.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.31 0.576 . . . . 2.01 109.853 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.75 157.91 27.51 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.566 -1.302 . . . . 1.22 110.806 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -64.21 150.32 46.09 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.956 . . . . 1.79 109.667 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -147.3 25.26 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.156 -1.018 . . . . 1.19 112.859 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.71 -59.86 0.09 Allowed 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 118.973 0.806 . . . . 1.85 111.376 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -138.66 17.04 2.7 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.626 -0.671 . . . . 2.25 110.346 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -171.55 144.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 O-C-N 121.193 -0.942 . . . . 1.87 109.979 -179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 35.5 t -99.35 112.52 24.68 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.945 -1.097 . . . . 0.7 110.482 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 25' ' ' ILE . 1.6 tt -114.01 58.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.919 0.866 . . . . 1.49 110.346 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.79 134.75 57.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.131 -0.981 . . . . 1.0 110.73 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.911 0 O-C-N 119.342 -2.099 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 120.926 0.393 . . . . 1.08 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -123.49 153.02 41.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.505 -0.747 . . . . 1.03 110.091 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.77 158.72 31.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.186 -0.946 . . . . 1.19 110.226 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.73 123.1 15.25 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.165 -0.959 . . . . 0.71 109.665 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.92 2.77 90.5 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.297 -0.954 . . . . 0.75 111.03 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.615 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 4.6 tt0 -76.79 -69.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.942 -1.328 . . . . 1.05 110.085 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.4 148.04 4.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.205 -0.935 . . . . 0.85 110.42 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -173.74 148.09 1.44 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.752 . . . . 0.73 110.119 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 2.3 m-20 -109.85 -176.25 2.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.6 -0.687 . . . . 1.38 109.576 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 10' ' ' ILE . 1.4 mp -79.82 -65.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 1.11 108.711 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 12' ' ' SER . 30.5 p90 -65.36 -37.14 86.13 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.707 0.765 . . . . 1.15 109.198 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.667 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 1.7 t -94.29 95.54 8.98 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.715 0.769 . . . . 1.01 109.742 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.7 129.41 36.13 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.298 -0.876 . . . . 0.59 109.847 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.693 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -118.89 19.06 13.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.15 -0.969 . . . . 0.94 111.724 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.698 ' SG ' ' HG3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -93.13 90.47 6.89 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.174 -0.954 . . . . 0.58 109.678 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.7 m -53.45 -32.97 52.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.449 -0.782 . . . . 0.95 111.43 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.1 48.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.288 -0.883 . . . . 1.46 111.307 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 15' ' ' CYS . . . 179.36 171.97 43.02 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.55 -1.31 . . . . 0.58 111.066 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -80.65 165.45 22.0 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.415 -1.05 . . . . 0.67 109.669 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -142.3 19.17 2.07 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.689 -1.257 . . . . 0.32 113.376 -178.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -24.13 -60.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.256 0.934 . . . . 0.55 111.63 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -137.78 13.22 2.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 1.29 110.466 178.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -173.39 149.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 O-C-N 121.416 -0.803 . . . . 0.75 109.398 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 11.1 t -99.02 112.93 24.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.992 -1.068 . . . . 0.55 110.631 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 23' ' ' ILE . 33.3 mt -125.42 88.58 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.551 -0.718 . . . . 1.37 109.409 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.698 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 71.7 mt-10 -80.55 154.22 27.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.027 -1.046 . . . . 1.56 110.832 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.92 0 O-C-N 119.227 -2.17 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.868 -0.419 . . . . 1.03 109.868 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -133.03 175.6 9.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.455 -0.778 . . . . 1.93 110.541 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 2.1 tt0 -80.98 150.24 29.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 1.6 110.581 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' N ' ' HG2' ' A' ' 3' ' ' GLN . . . -60.71 131.44 50.71 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.436 -0.79 . . . . 1.26 110.133 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.8 70.98 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.491 -0.862 . . . . 0.83 111.029 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 3' ' ' GLN . 3.4 tt0 -83.19 -66.64 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.957 -1.319 . . . . 0.97 110.941 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -171.9 146.1 1.98 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.169 -0.957 . . . . 0.5 110.733 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.636 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 41.2 t -170.68 154.42 4.45 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.271 -0.893 . . . . 0.5 110.956 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.611 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 3.3 m-20 -104.52 -173.51 2.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.705 -0.622 . . . . 0.69 109.898 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.1 mp -88.53 -66.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.211 -0.93 . . . . 0.89 108.56 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 29.5 p90 -64.83 -36.85 85.65 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.863 0.84 . . . . 0.94 109.005 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.611 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 2.2 t -94.05 93.65 7.97 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.716 0.77 . . . . 0.68 109.574 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -86.53 133.66 33.72 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.099 -1.001 . . . . 0.54 109.885 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.703 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 1.9 m-80 -117.78 12.21 13.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.892 -1.13 . . . . 0.74 111.901 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.71 106.48 8.4 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 120.936 -1.102 . . . . 0.73 109.323 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.4 m -44.36 -31.5 1.06 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.586 -0.696 . . . . 0.82 111.302 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.0 p -156.25 49.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.807 0.813 . . . . 0.61 109.957 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.23 168.67 34.14 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.568 -1.301 . . . . 0.6 111.15 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.42 150.57 33.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.574 -0.957 . . . . 1.59 110.043 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -132.91 15.97 4.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.911 -1.118 . . . . 0.56 112.973 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -20.08 -63.53 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 118.902 0.774 . . . . 0.79 111.974 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -136.04 11.3 3.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 1.69 110.291 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -169.18 143.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.463 -0.773 . . . . 1.03 108.961 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 49.3 t -95.71 114.02 25.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.798 -1.189 . . . . 0.63 110.705 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 25' ' ' ILE . 1.4 tp -129.08 124.46 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.402 0.62 . . . . 1.26 110.137 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 153.06 30.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.35 110.342 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.891 0 O-C-N 119.361 -2.087 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 109.65 -0.5 . . . . 0.44 109.65 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -157.36 125.52 5.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.657 -0.652 . . . . 0.46 110.082 -179.396 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 10.0 mp0 -51.11 149.28 3.83 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.552 0.691 . . . . 1.29 111.446 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 25' ' ' ILE . . . -50.23 132.28 24.01 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.502 -0.749 . . . . 0.37 110.708 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.15 -35.22 5.19 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.643 -1.383 . . . . 0.33 109.643 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -55.16 151.18 9.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.505 -0.997 . . . . 0.79 111.098 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.28 157.36 0.48 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.464 0.649 . . . . 0.67 111.558 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.409 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 41.0 t -170.52 149.31 3.24 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.251 -0.905 . . . . 0.33 110.914 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.646 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 1.4 m-20 -102.3 -179.23 3.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 0.52 109.586 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.08 -73.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.057 -1.027 . . . . 0.6 108.793 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.6 p90 -57.19 -38.14 73.23 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.739 0.78 . . . . 0.54 109.307 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 4.0 t -94.37 98.66 11.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.714 0.768 . . . . 0.43 109.647 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.62 140.69 33.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.317 -0.864 . . . . 0.51 110.357 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 8' ' ' CYS . 2.0 m-80 -96.65 -19.75 18.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.066 -1.021 . . . . 0.38 110.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.9 m -79.23 111.47 15.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.129 -0.982 . . . . 0.26 109.698 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.31 -35.61 8.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.358 -0.839 . . . . 0.42 109.928 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 17' ' ' VAL . 14.5 p -142.71 52.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.535 0.683 . . . . 0.52 110.2 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.3 151.42 23.47 Favored Glycine 0 N--CA 1.5 2.904 0 C-N-CA 119.461 -1.352 . . . . 0.28 110.964 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.28 124.85 24.92 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.476 -1.014 . . . . 0.77 109.589 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -123.76 23.34 8.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.207 -0.933 . . . . 0.27 112.472 -178.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -26.51 -56.96 0.08 Allowed 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.628 -0.67 . . . . 0.4 112.084 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -139.23 15.74 2.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.437 -0.79 . . . . 1.4 110.405 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -175.29 145.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.493 -0.754 . . . . 0.66 109.345 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 29.1 t -99.15 136.46 39.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.27 111.726 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.589 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 3.8 mt -126.78 53.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.536 0.684 . . . . 0.88 109.553 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 2' ' ' LYS . 3.2 tt0 -84.11 127.27 33.8 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.979 -1.076 . . . . 0.51 110.481 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.379 1.873 0 O-C-N 119.419 -2.051 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 26.1 t . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 110.001 -0.37 . . . . 0.54 110.001 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HG2' ' CD ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -149.87 -174.29 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.555 -0.716 . . . . 0.72 110.549 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 6.4 tp-100 -79.67 152.69 29.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.767 . . . . 1.15 110.559 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . . . -57.41 133.69 55.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.367 -0.833 . . . . 0.4 110.121 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.65 -14.22 64.41 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.571 -1.012 . . . . 0.34 110.571 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -77.06 -170.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.278 . . . . 0.58 110.681 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 146.99 52.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.169 -0.957 . . . . 1.08 111.535 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.669 ' SG ' ' HA ' ' A' ' 13' ' ' GLN . 19.4 t -171.71 156.46 4.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.552 -0.717 . . . . 0.38 110.848 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 4.0 m-20 -113.64 -175.33 2.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.68 -0.637 . . . . 0.52 109.915 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 10' ' ' ILE . 2.0 mp -78.32 -66.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.296 -0.877 . . . . 0.56 108.929 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 12' ' ' SER . 31.5 p90 -69.05 -38.14 78.93 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.745 0.783 . . . . 0.52 109.387 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . 5.1 t -94.94 95.85 8.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.807 -0.812 . . . . 0.5 108.807 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.669 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -96.01 150.19 20.74 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.215 -0.928 . . . . 0.45 112.014 -177.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 1.4 m-20 -111.64 -1.33 15.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.443 -0.785 . . . . 0.49 110.572 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 m -88.17 96.04 10.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.954 -1.091 . . . . 0.33 109.783 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -55.11 -26.15 36.31 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.201 -0.937 . . . . 0.69 110.933 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.45 46.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.203 -0.935 . . . . 0.75 110.802 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' HA3' ' HG3' ' A' ' 26' ' ' GLU . . . -171.55 165.0 37.89 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.411 -1.076 . . . . 0.77 110.411 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -84.26 167.9 16.19 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.335 -1.097 . . . . 0.79 110.382 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -143.17 24.81 1.78 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.271 -0.893 . . . . 0.69 112.523 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 20' ' ' CYS . . . -17.88 -66.75 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 118.582 0.628 . . . . 0.73 111.95 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' C ' ' CG1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -131.14 6.47 4.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.539 -0.726 . . . . 1.66 110.815 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -168.13 152.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.741 -0.837 . . . . 0.71 108.741 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.623 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 30.1 t -86.15 118.04 25.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.45 111.233 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 25' ' ' ILE . 1.3 tp -140.66 124.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.316 0.579 . . . . 1.38 110.009 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HG3' ' HA3' ' A' ' 18' ' ' GLY . 2.3 mt-10 -122.14 -155.0 0.62 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.226 -0.921 . . . . 1.24 110.797 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 1.912 0 O-C-N 119.219 -2.176 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_